data_1fge_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fge _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.502 2.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 35.7 Cg_endo -74.79 -171.8 1.06 Allowed 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 123.192 2.595 . . . . 0.0 112.801 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.64 127.64 33.19 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.2 5.73 Favored Glycine 0 N--CA 1.51 3.627 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -75.54 133.81 40.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 122.854 0.461 . . . . 0.0 110.024 179.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.865 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 423' ' ' ASP . 0.4 OUTLIER -113.72 123.51 50.04 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.696 0.76 . . . . 0.0 109.525 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.19 -23.2 67.23 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.443 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -19.38 65.78 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 118.541 0.609 . . . . 0.0 111.177 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 123.55 -11.05 8.5 Favored Glycine 0 N--CA 1.506 3.346 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 11.2 t80 77.11 147.15 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 118.123 0.962 . . . . 0.0 111.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.85 -63.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.457 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 27.2 t 177.68 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.2 m 69.84 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 122.943 0.497 . . . . 0.0 109.689 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.483 ' HB3' HD22 ' A' ' 415' ' ' LEU . 10.9 m-20 -148.12 -53.48 0.19 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.054 -0.404 . . . . 0.0 111.243 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.96 -32.91 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.368 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . 0.403 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 16.2 m-20 . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.7 Cg_endo -71.11 -176.46 1.87 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 123.239 2.626 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.19 125.55 22.25 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 120.941 0.4 . . . . 0.0 110.384 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.91 -37.97 3.26 Favored Glycine 0 N--CA 1.51 3.624 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.17 136.86 46.58 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 122.926 0.49 . . . . 0.0 109.819 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 3.0 tp -169.71 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 CA-C-O 121.147 0.499 . . . . 0.0 110.622 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -101.77 110.61 22.63 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.366 0.603 . . . . 0.0 109.445 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -25.74 68.3 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.804 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.88 -27.41 66.67 Favored 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 122.396 0.278 . . . . 0.0 111.173 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 141.58 -31.43 2.13 Favored Glycine 0 N--CA 1.512 3.722 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.431 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 17.4 t80 75.14 148.83 0.1 Allowed 'General case' 0 N--CA 1.51 2.555 0 CA-C-O 122.116 0.96 . . . . 0.0 112.745 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.86 -59.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.65 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.9 t 178.13 96.12 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.2 m 70.21 122.66 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.145 0.578 . . . . 0.0 110.082 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.453 ' HB2' HD22 ' A' ' 415' ' ' LEU . 9.6 m-20 -145.75 -60.68 0.33 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.075 -0.391 . . . . 0.0 111.031 -178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.91 -32.23 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 O-C-N 122.233 -0.292 . . . . 0.0 111.137 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.126 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.7 Cg_endo -70.76 -177.19 2.07 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 123.165 2.576 . . . . 0.0 113.096 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.6 125.75 23.6 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.342 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.66 -36.99 3.54 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.26 136.29 44.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.403 -0.469 . . . . 0.0 110.013 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.9 tp -171.1 104.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.111 0.481 . . . . 0.0 110.675 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -98.53 112.55 24.55 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.26 -28.84 69.46 Favored 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.54 -31.66 68.16 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.299 -0.251 . . . . 0.0 110.942 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 147.36 -31.45 1.41 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.406 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.1 t80 75.03 147.25 0.09 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.277 1.037 . . . . 0.0 113.098 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.18 -63.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.5 t -179.49 105.94 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 67.16 116.53 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.558 0.694 . . . . 0.0 110.231 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.476 ' HB2' HD22 ' A' ' 415' ' ' LEU . 15.5 m-20 -149.76 -60.91 0.21 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.849 -0.532 . . . . 0.0 111.128 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.9 pt -75.9 -36.76 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 O-C-N 122.191 -0.318 . . . . 0.0 111.765 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.227 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.4 Cg_endo -70.83 -177.62 2.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.164 2.576 . . . . 0.0 113.161 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.42 125.78 23.52 Favored 'General case' 0 N--CA 1.516 2.838 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.458 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.45 -37.09 3.5 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.07 136.04 44.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.353 -0.498 . . . . 0.0 110.012 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.68 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 CA-C-O 121.188 0.518 . . . . 0.0 110.519 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -99.59 112.08 24.34 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.23 -27.36 67.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 122.247 -0.283 . . . . 0.0 111.118 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.96 -33.41 1.63 Allowed Glycine 0 N--CA 1.511 3.669 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.424 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 29.1 t80 73.05 147.64 0.09 Allowed 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.15 0.976 . . . . 0.0 113.015 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 -63.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.42 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.8 m 70.02 118.61 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 122.989 0.516 . . . . 0.0 109.888 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.457 ' HB2' HD22 ' A' ' 415' ' ' LEU . 11.8 m-20 -148.28 -54.79 0.2 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.226 -0.296 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.6 pt -81.39 -29.4 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.502 2.154 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.377 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -71.86 -173.92 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.293 2.662 . . . . 0.0 113.319 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.21 125.3 20.08 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-O 120.966 0.413 . . . . 0.0 110.459 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.01 -34.49 4.76 Favored Glycine 0 N--CA 1.509 3.553 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -74.33 134.07 42.54 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 117.17 0.485 . . . . 0.0 110.225 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -172.38 102.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.439 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.5 mm? -96.79 112.99 24.51 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.65 -26.94 68.89 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.97 -26.88 67.87 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 122.208 -0.307 . . . . 0.0 111.17 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.07 -33.39 1.72 Allowed Glycine 0 N--CA 1.51 3.613 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.439 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.4 t80 73.72 147.62 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.193 0.997 . . . . 0.0 113.139 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 -61.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.282 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 7.5 t 179.5 110.88 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.5 m 64.49 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 120.999 0.428 . . . . 0.0 109.914 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.427 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 13.2 m-20 -142.25 -37.13 0.4 Allowed 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.61 -24.36 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.511 2.581 0 CA-C-N 119.222 0.919 . . . . 0.0 111.0 -178.827 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.4 Cg_endo -70.95 -176.38 1.79 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.218 2.612 . . . . 0.0 113.163 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.24 125.43 21.76 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.54 -37.53 3.38 Favored Glycine 0 N--CA 1.511 3.645 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.98 136.75 45.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 122.859 0.464 . . . . 0.0 109.997 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.6 103.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.789 0 CA-C-O 121.231 0.539 . . . . 0.0 111.224 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.451 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.6 mm? -101.02 104.31 15.45 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.34 -20.49 66.42 Favored 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 122.022 -0.424 . . . . 0.0 110.564 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 152.63 -39.95 0.73 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.451 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 31.7 t80 71.82 147.92 0.08 Allowed 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 122.332 1.063 . . . . 0.0 113.144 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.13 -62.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.7 t 178.48 112.68 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 83.9 m 66.24 103.93 0.04 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.427 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 10.7 m-20 -143.05 -39.2 0.33 Allowed 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.8 pt -104.1 -24.17 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.51 2.553 0 CA-C-N 119.271 0.941 . . . . 0.0 111.068 -178.776 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.502 2.142 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -72.2 -172.26 0.85 Allowed 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 123.267 2.645 . . . . 0.0 113.112 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.06 128.83 39.18 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-O 121.0 0.429 . . . . 0.0 110.288 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 84.22 -5.38 80.51 Favored Glycine 0 N--CA 1.512 3.718 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -104.86 138.73 40.66 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 118.22 1.01 . . . . 0.0 109.705 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.4 tp -172.35 105.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 CA-C-O 121.173 0.511 . . . . 0.0 110.902 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.466 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.6 mm? -103.67 102.96 12.83 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.02 -19.76 65.96 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.14 -27.75 69.29 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 122.019 -0.426 . . . . 0.0 110.518 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 155.1 -41.58 0.6 Allowed Glycine 0 N--CA 1.511 3.655 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.466 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 34.2 t80 70.88 148.11 0.08 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.233 1.016 . . . . 0.0 113.079 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.78 -63.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.9 t -177.84 101.27 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.4 m 70.85 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.131 0 C-N-CA 123.01 0.524 . . . . 0.0 109.693 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.443 ' HB2' HD22 ' A' ' 415' ' ' LEU . 8.9 m-20 -147.84 -54.12 0.21 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.19 -0.319 . . . . 0.0 111.148 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.6 pt -81.44 -29.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 O-C-N 122.105 -0.372 . . . . 0.0 111.941 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.431 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.86 -171.96 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.088 2.525 . . . . 0.0 112.172 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.82 129.27 41.3 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 122.024 -0.423 . . . . 0.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.99 -30.26 8.78 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.446 ' HB3' ' CB ' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -76.42 135.05 39.44 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 117.528 0.664 . . . . 0.0 110.009 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -165.88 112.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-O 121.051 0.453 . . . . 0.0 111.136 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 423' ' ' ASP . 0.4 OUTLIER -111.14 122.81 48.82 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.535 0.683 . . . . 0.0 109.778 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.33 -23.93 67.14 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.877 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -15.69 63.63 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-N 118.357 0.526 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 119.87 -4.97 12.75 Favored Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 409' ' ' ALA . 17.9 t80 77.68 146.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.206 1.003 . . . . 0.0 112.687 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.92 -57.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.537 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 6.6 t -171.14 -132.61 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.875 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 80.3 m -72.12 107.72 4.94 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.778 -1.202 . . . . 0.0 107.884 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 415' ' ' LEU . 4.3 m-20 -125.41 -30.85 3.08 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.79 -11.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 CA-C-N 118.965 0.802 . . . . 0.0 112.671 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.506 2.333 0 CA-C-N 119.283 0.947 . . . . 0.0 110.81 -179.64 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 110.505 -0.184 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.79 -177.94 3.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.965 2.443 . . . . 0.0 112.285 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 130.76 48.13 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 121.988 -0.445 . . . . 0.0 110.301 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.71 -28.32 12.85 Favored Glycine 0 N--CA 1.511 3.673 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.05 137.31 45.24 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 117.811 0.805 . . . . 0.0 110.185 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.8 tp -161.9 111.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-O 121.168 0.509 . . . . 0.0 110.888 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 423' ' ' ASP . 3.7 mm? -104.67 116.96 32.94 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -25.95 68.49 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.85 -9.36 57.43 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 122.038 -0.414 . . . . 0.0 111.851 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 117.45 -3.91 17.86 Favored Glycine 0 N--CA 1.512 3.73 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.425 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 24.1 t80 73.56 146.28 0.08 Allowed 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.252 1.025 . . . . 0.0 113.21 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -59.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.151 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 5.5 t -166.98 -129.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.1 t -75.17 131.73 40.65 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 119.842 1.201 . . . . 0.0 108.938 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.491 ' HB2' HD22 ' A' ' 415' ' ' LEU . 17.1 m-20 -145.61 -55.02 0.29 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.553 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.9 pt -84.56 -32.89 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 O-C-N 122.015 -0.428 . . . . 0.0 111.285 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 N--CA 1.505 2.311 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.85 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.507 2.416 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.09 -174.57 2.13 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.961 2.44 . . . . 0.0 112.146 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.54 129.8 43.75 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 122.015 -0.428 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.89 -29.29 10.12 Favored Glycine 0 N--CA 1.51 3.582 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.421 ' HB3' ' CB ' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.86 137.92 44.05 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 117.601 0.701 . . . . 0.0 110.297 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.65 111.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 CA-C-O 121.221 0.534 . . . . 0.0 111.191 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 423' ' ' ASP . 3.6 mm? -106.03 118.69 37.27 Favored 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -62.56 -25.67 68.18 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.948 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.22 2.41 13.25 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.929 -0.482 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.52 8.18 46.92 Favored Glycine 0 N--CA 1.511 3.674 0 O-C-N 121.122 -0.986 . . . . 0.0 110.816 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 17.2 t80 71.2 148.05 0.08 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.18 0.99 . . . . 0.0 113.218 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.29 -56.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.704 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.3 t -173.72 -125.14 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.2 m -78.37 124.39 28.05 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.912 -1.118 . . . . 0.0 108.474 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.483 ' HB2' HD22 ' A' ' 415' ' ' LEU . 19.3 m-20 -144.22 -54.67 0.35 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.436 -0.165 . . . . 0.0 111.283 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.5 pt -85.56 -29.85 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.801 0 O-C-N 121.869 -0.52 . . . . 0.0 111.556 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 . . . . . 0 N--CA 1.504 2.263 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 36.4 Cg_endo -74.87 -168.24 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 123.324 2.683 . . . . 0.0 112.91 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 131.58 51.4 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.3 89.13 Favored Glycine 0 N--CA 1.511 3.67 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.51 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -111.87 137.69 49.5 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.344 1.072 . . . . 0.0 109.875 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.5 tp -171.4 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 CA-C-O 121.216 0.532 . . . . 0.0 110.359 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.6 mm? -100.74 112.03 24.37 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.388 0.613 . . . . 0.0 109.386 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.28 -26.29 68.71 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.008 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.38 -26.72 66.86 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 122.244 -0.285 . . . . 0.0 111.203 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.01 -28.93 2.47 Favored Glycine 0 N--CA 1.51 3.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.437 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 18.2 t80 75.01 148.35 0.1 Allowed 'General case' 0 N--CA 1.51 2.545 0 CA-C-O 122.04 0.924 . . . . 0.0 112.706 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 -60.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.711 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.4 t 178.9 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 m 70.29 122.46 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.063 0.545 . . . . 0.0 109.961 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.489 ' HB2' HD22 ' A' ' 415' ' ' LEU . 12.4 m-20 -148.68 -52.22 0.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.224 -0.298 . . . . 0.0 111.331 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.6 pt -85.02 -28.41 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 O-C-N 121.996 -0.44 . . . . 0.0 111.824 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.503 2.199 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.205 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.507 2.395 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.03 -176.81 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 123.042 2.495 . . . . 0.0 112.202 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.62 131.2 49.24 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 122.014 -0.429 . . . . 0.0 110.298 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.64 -23.94 30.18 Favored Glycine 0 N--CA 1.51 3.628 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.434 ' HB3' ' CB ' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -75.55 138.03 41.23 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 118.022 0.911 . . . . 0.0 110.368 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.01 111.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-O 121.121 0.486 . . . . 0.0 111.014 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.503 HD22 ' HB2' ' A' ' 423' ' ' ASP . 3.5 mm? -105.01 118.66 37.09 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.92 -25.4 68.31 Favored 'General case' 0 N--CA 1.518 2.961 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.876 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.28 0.45 16.59 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.992 -0.442 . . . . 0.0 111.958 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.43 5.49 42.68 Favored Glycine 0 N--CA 1.511 3.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.423 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 23.1 t80 70.97 146.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.38 1.086 . . . . 0.0 113.405 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 -59.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.324 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 4.9 t -168.18 -131.07 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.9 m -76.11 120.71 21.78 Favored 'General case' 0 N--CA 1.512 2.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.441 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.503 ' HB2' HD22 ' A' ' 415' ' ' LEU . 20.8 m-20 -139.34 -60.54 0.56 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.459 -0.151 . . . . 0.0 110.934 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.1 pt -72.37 -29.09 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 122.082 -0.386 . . . . 0.0 110.86 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.502 2.152 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.043 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 33.7 Cg_endo -72.15 -174.76 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.276 2.651 . . . . 0.0 112.978 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.67 125.85 24.11 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.373 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.08 -36.74 3.66 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.9 135.66 45.13 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.415 -0.462 . . . . 0.0 109.991 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -170.21 102.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 CA-C-O 121.214 0.531 . . . . 0.0 110.665 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -96.19 113.2 24.78 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.13 -26.36 67.63 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 122.134 -0.354 . . . . 0.0 111.223 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.55 2.32 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.414 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 24.0 t80 74.82 147.83 0.09 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 122.213 1.006 . . . . 0.0 112.818 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.01 -60.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.243 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.2 t 177.26 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 68.1 m 65.16 107.1 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 120.973 0.416 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.441 ' HB2' HD22 ' A' ' 415' ' ' LEU . 17.9 m-20 -144.19 -39.49 0.29 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.6 pt -102.54 -23.49 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.511 2.596 0 CA-C-N 119.29 0.95 . . . . 0.0 111.005 -178.76 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.238 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.5 Cg_endo -70.37 -178.0 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.234 2.622 . . . . 0.0 113.169 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.61 125.6 22.94 Favored 'General case' 0 N--CA 1.517 2.889 0 CA-C-O 120.965 0.412 . . . . 0.0 110.375 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.53 -37.48 3.4 Favored Glycine 0 N--CA 1.51 3.617 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.54 137.34 44.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.978 0.511 . . . . 0.0 110.076 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.8 tp -173.22 107.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.601 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -102.26 111.17 23.35 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.26 -25.85 68.51 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.09 -26.86 66.53 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.09 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.51 -32.87 1.71 Allowed Glycine 0 N--CA 1.51 3.593 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' PHE . . . . . 0.428 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 26.2 t80 72.67 148.84 0.09 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 122.006 0.907 . . . . 0.0 112.617 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -62.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.927 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 17.4 t -179.4 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.2 m 70.73 121.65 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.001 0.52 . . . . 0.0 109.657 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' ASP . . . . . 0.446 ' HB2' HD22 ' A' ' 415' ' ' LEU . 7.5 m-20 -145.99 -55.89 0.29 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.12 -0.362 . . . . 0.0 111.066 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.3 pt -81.21 -29.17 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.504 2.23 0 CA-C-O 121.822 0.82 . . . . 0.0 108.834 179.742 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 420' ' ' ILE . 33.4 m . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.335 0.588 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -120.44 160.7 22.58 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.333 0.587 . . . . 0.0 111.316 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -109.24 115.17 56.96 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 35.7 Cg_endo -74.79 -171.8 1.06 Allowed 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 123.192 2.595 . . . . 0.0 112.801 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.64 127.64 33.19 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.2 5.73 Favored Glycine 0 N--CA 1.51 3.627 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -75.54 133.81 40.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 122.854 0.461 . . . . 0.0 110.024 179.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.865 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 423' ' ' ASP . 0.4 OUTLIER -113.72 123.51 50.04 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.696 0.76 . . . . 0.0 109.525 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.19 -23.2 67.23 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.443 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -19.38 65.78 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 118.541 0.609 . . . . 0.0 111.177 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 123.55 -11.05 8.5 Favored Glycine 0 N--CA 1.506 3.346 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 11.2 t80 77.11 147.15 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 118.123 0.962 . . . . 0.0 111.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 407' ' ' CYS . 0.1 OUTLIER -138.85 -63.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.457 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.42 ' HA ' ' CB ' ' A' ' 407' ' ' CYS . 27.2 t 177.68 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.476 HG21 ' HG2' ' A' ' 426' ' ' GLU . 7.2 m 69.84 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 122.943 0.497 . . . . 0.0 109.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.483 ' HB3' HD22 ' A' ' 415' ' ' LEU . 10.9 m-20 -148.12 -53.48 0.19 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.054 -0.404 . . . . 0.0 111.243 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.96 -32.91 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.368 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . 0.403 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 16.2 m-20 -112.3 72.69 0.78 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.476 ' HG2' HG21 ' A' ' 422' ' ' THR . 2.0 mt-10 . . . . . 0 N--CA 1.51 2.568 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 121.049 0.452 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.09 159.03 23.93 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 121.213 0.53 . . . . 0.0 110.913 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -83.15 120.18 75.45 Favored Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.7 Cg_endo -71.11 -176.46 1.87 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 123.239 2.626 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.19 125.55 22.25 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 120.941 0.4 . . . . 0.0 110.384 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.91 -37.97 3.26 Favored Glycine 0 N--CA 1.51 3.624 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.17 136.86 46.58 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 122.926 0.49 . . . . 0.0 109.819 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 3.0 tp -169.71 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 CA-C-O 121.147 0.499 . . . . 0.0 110.622 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -101.77 110.61 22.63 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.366 0.603 . . . . 0.0 109.445 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -25.74 68.3 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.804 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.88 -27.41 66.67 Favored 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 122.396 0.278 . . . . 0.0 111.173 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 141.58 -31.43 2.13 Favored Glycine 0 N--CA 1.512 3.722 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.431 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 17.4 t80 75.14 148.83 0.1 Allowed 'General case' 0 N--CA 1.51 2.555 0 CA-C-O 122.116 0.96 . . . . 0.0 112.745 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.86 -59.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.65 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.9 t 178.13 96.12 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.2 m 70.21 122.66 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.145 0.578 . . . . 0.0 110.082 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.453 ' HB2' HD22 ' A' ' 415' ' ' LEU . 9.6 m-20 -145.75 -60.68 0.33 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.075 -0.391 . . . . 0.0 111.031 -178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.91 -32.23 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 O-C-N 122.233 -0.292 . . . . 0.0 111.137 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.64 62.12 0.71 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.512 2.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 -179.19 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.6 148.27 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 CA-C-O 121.822 0.82 . . . . 0.0 112.261 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -91.41 124.48 61.02 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.853 -0.529 . . . . 0.0 109.818 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.7 Cg_endo -70.76 -177.19 2.07 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 123.165 2.576 . . . . 0.0 113.096 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.6 125.75 23.6 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.342 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.66 -36.99 3.54 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.26 136.29 44.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.403 -0.469 . . . . 0.0 110.013 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.9 tp -171.1 104.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.111 0.481 . . . . 0.0 110.675 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -98.53 112.55 24.55 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.26 -28.84 69.46 Favored 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.54 -31.66 68.16 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.299 -0.251 . . . . 0.0 110.942 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 147.36 -31.45 1.41 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.406 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.1 t80 75.03 147.25 0.09 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.277 1.037 . . . . 0.0 113.098 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.18 -63.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.5 t -179.49 105.94 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.713 HG21 ' HXT' ' A' ' 426' ' ' GLU . 0.4 OUTLIER 67.16 116.53 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.558 0.694 . . . . 0.0 110.231 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.476 ' HB2' HD22 ' A' ' 415' ' ' LEU . 15.5 m-20 -149.76 -60.91 0.21 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.849 -0.532 . . . . 0.0 111.128 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.9 pt -75.9 -36.76 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 O-C-N 122.191 -0.318 . . . . 0.0 111.765 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.65 65.63 0.77 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.713 ' HXT' HG21 ' A' ' 422' ' ' THR . 2.3 mp0 . . . . . 0 N--CA 1.508 2.437 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.761 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.41 150.58 0.06 Allowed 'General case' 0 N--CA 1.517 2.88 0 CA-C-O 121.809 0.814 . . . . 0.0 112.308 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -93.95 125.84 51.44 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.902 -0.499 . . . . 0.0 109.864 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.4 Cg_endo -70.83 -177.62 2.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.164 2.576 . . . . 0.0 113.161 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.42 125.78 23.52 Favored 'General case' 0 N--CA 1.516 2.838 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.458 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.45 -37.09 3.5 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.07 136.04 44.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.353 -0.498 . . . . 0.0 110.012 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.68 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 CA-C-O 121.188 0.518 . . . . 0.0 110.519 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -99.59 112.08 24.34 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.23 -27.36 67.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 122.247 -0.283 . . . . 0.0 111.118 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.96 -33.41 1.63 Allowed Glycine 0 N--CA 1.511 3.669 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.424 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 29.1 t80 73.05 147.64 0.09 Allowed 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.15 0.976 . . . . 0.0 113.015 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 -63.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.42 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.494 HG21 ' HG2' ' A' ' 426' ' ' GLU . 6.8 m 70.02 118.61 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 122.989 0.516 . . . . 0.0 109.888 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.457 ' HB2' HD22 ' A' ' 415' ' ' LEU . 11.8 m-20 -148.28 -54.79 0.2 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.226 -0.296 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.6 pt -81.39 -29.4 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.7 71.28 0.85 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.494 ' HG2' HG21 ' A' ' 422' ' ' THR . 11.8 mt-10 . . . . . 0 N--CA 1.512 2.649 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.379 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.72 174.25 10.82 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 121.439 0.638 . . . . 0.0 111.42 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -108.52 112.89 60.57 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -71.86 -173.92 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.293 2.662 . . . . 0.0 113.319 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.21 125.3 20.08 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-O 120.966 0.413 . . . . 0.0 110.459 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.01 -34.49 4.76 Favored Glycine 0 N--CA 1.509 3.553 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -74.33 134.07 42.54 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 117.17 0.485 . . . . 0.0 110.225 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -172.38 102.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.439 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.5 mm? -96.79 112.99 24.51 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.65 -26.94 68.89 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.97 -26.88 67.87 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 122.208 -0.307 . . . . 0.0 111.17 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.07 -33.39 1.72 Allowed Glycine 0 N--CA 1.51 3.613 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.439 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.4 t80 73.72 147.62 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.193 0.997 . . . . 0.0 113.139 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 -61.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.282 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 7.5 t 179.5 110.88 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.5 m 64.49 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 120.999 0.428 . . . . 0.0 109.914 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.427 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 13.2 m-20 -142.25 -37.13 0.4 Allowed 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.61 -24.36 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.91 64.81 1.26 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 119.222 0.919 . . . . 0.0 111.0 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.507 2.393 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.386 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.27 150.65 0.05 Allowed 'General case' 0 N--CA 1.516 2.857 0 CA-C-O 121.742 0.782 . . . . 0.0 112.264 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -91.57 122.45 65.77 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 121.871 -0.518 . . . . 0.0 109.764 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.4 Cg_endo -70.95 -176.38 1.79 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.218 2.612 . . . . 0.0 113.163 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.24 125.43 21.76 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.54 -37.53 3.38 Favored Glycine 0 N--CA 1.511 3.645 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.98 136.75 45.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 122.859 0.464 . . . . 0.0 109.997 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.6 103.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.789 0 CA-C-O 121.231 0.539 . . . . 0.0 111.224 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.451 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.6 mm? -101.02 104.31 15.45 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.34 -20.49 66.42 Favored 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 122.022 -0.424 . . . . 0.0 110.564 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 152.63 -39.95 0.73 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.451 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 31.7 t80 71.82 147.92 0.08 Allowed 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 122.332 1.063 . . . . 0.0 113.144 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.13 -62.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.7 t 178.48 112.68 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 83.9 m 66.24 103.93 0.04 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.427 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 10.7 m-20 -143.05 -39.2 0.33 Allowed 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.8 pt -104.1 -24.17 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.67 64.36 1.28 Allowed 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 119.271 0.941 . . . . 0.0 111.068 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.506 2.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.383 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.32 154.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 121.896 0.855 . . . . 0.0 112.774 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -92.8 122.51 63.79 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -72.2 -172.26 0.85 Allowed 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 123.267 2.645 . . . . 0.0 113.112 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.06 128.83 39.18 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-O 121.0 0.429 . . . . 0.0 110.288 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 84.22 -5.38 80.51 Favored Glycine 0 N--CA 1.512 3.718 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -104.86 138.73 40.66 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 118.22 1.01 . . . . 0.0 109.705 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.4 tp -172.35 105.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 CA-C-O 121.173 0.511 . . . . 0.0 110.902 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.466 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.6 mm? -103.67 102.96 12.83 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.02 -19.76 65.96 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.14 -27.75 69.29 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 122.019 -0.426 . . . . 0.0 110.518 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 155.1 -41.58 0.6 Allowed Glycine 0 N--CA 1.511 3.655 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.466 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 34.2 t80 70.88 148.11 0.08 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.233 1.016 . . . . 0.0 113.079 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.78 -63.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.9 t -177.84 101.27 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.49 HG21 ' HG2' ' A' ' 426' ' ' GLU . 7.4 m 70.85 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.131 0 C-N-CA 123.01 0.524 . . . . 0.0 109.693 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.443 ' HB2' HD22 ' A' ' 415' ' ' LEU . 8.9 m-20 -147.84 -54.12 0.21 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.19 -0.319 . . . . 0.0 111.148 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.6 pt -81.44 -29.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 O-C-N 122.105 -0.372 . . . . 0.0 111.941 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.83 71.16 0.83 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.49 ' HG2' HG21 ' A' ' 422' ' ' THR . 10.7 mt-10 . . . . . 0 N--CA 1.512 2.637 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.417 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 6.0 m . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.36 161.29 25.0 Favored 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.337 0.589 . . . . 0.0 111.164 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 413' ' ' TYR . . . -105.5 116.36 60.29 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 122.09 -0.381 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.86 -171.96 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.088 2.525 . . . . 0.0 112.172 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.82 129.27 41.3 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 122.024 -0.423 . . . . 0.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.99 -30.26 8.78 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.446 ' HB3' ' CB ' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -76.42 135.05 39.44 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 117.528 0.664 . . . . 0.0 110.009 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -165.88 112.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-O 121.051 0.453 . . . . 0.0 111.136 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 423' ' ' ASP . 0.4 OUTLIER -111.14 122.81 48.82 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.535 0.683 . . . . 0.0 109.778 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.33 -23.93 67.14 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.877 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -15.69 63.63 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-N 118.357 0.526 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 119.87 -4.97 12.75 Favored Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 409' ' ' ALA . 17.9 t80 77.68 146.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.206 1.003 . . . . 0.0 112.687 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.92 -57.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.537 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 407' ' ' CYS . 6.6 t -171.14 -132.61 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.875 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 80.3 m -72.12 107.72 4.94 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.778 -1.202 . . . . 0.0 107.884 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 415' ' ' LEU . 4.3 m-20 -125.41 -30.85 3.08 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.79 -11.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 CA-C-N 118.965 0.802 . . . . 0.0 112.671 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.96 75.5 1.01 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.283 0.947 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.51 2.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.233 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 65.93 153.63 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 CA-C-O 121.729 0.776 . . . . 0.0 112.482 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 413' ' ' TYR . . . -114.56 133.49 22.5 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 121.916 -0.49 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.79 -177.94 3.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.965 2.443 . . . . 0.0 112.285 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 130.76 48.13 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 121.988 -0.445 . . . . 0.0 110.301 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.71 -28.32 12.85 Favored Glycine 0 N--CA 1.511 3.673 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.05 137.31 45.24 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 117.811 0.805 . . . . 0.0 110.185 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.8 tp -161.9 111.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-O 121.168 0.509 . . . . 0.0 110.888 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 423' ' ' ASP . 3.7 mm? -104.67 116.96 32.94 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -25.95 68.49 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.85 -9.36 57.43 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 122.038 -0.414 . . . . 0.0 111.851 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 117.45 -3.91 17.86 Favored Glycine 0 N--CA 1.512 3.73 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.425 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 24.1 t80 73.56 146.28 0.08 Allowed 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.252 1.025 . . . . 0.0 113.21 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -59.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.151 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 5.5 t -166.98 -129.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.4 HG22 ' HG2' ' A' ' 426' ' ' GLU . 8.1 t -75.17 131.73 40.65 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 119.842 1.201 . . . . 0.0 108.938 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.491 ' HB2' HD22 ' A' ' 415' ' ' LEU . 17.1 m-20 -145.61 -55.02 0.29 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.553 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.9 pt -84.56 -32.89 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 O-C-N 122.015 -0.428 . . . . 0.0 111.285 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -115.23 71.7 0.77 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.4 ' HG2' HG22 ' A' ' 422' ' ' THR . 36.5 mt-10 . . . . . 0 N--CA 1.509 2.496 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.369 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.725 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -122.14 151.1 41.3 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 413' ' ' TYR . . . -99.99 120.82 55.94 Favored Pre-proline 0 N--CA 1.507 2.416 0 O-C-N 122.104 -0.372 . . . . 0.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.09 -174.57 2.13 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.961 2.44 . . . . 0.0 112.146 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.54 129.8 43.75 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 122.015 -0.428 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.89 -29.29 10.12 Favored Glycine 0 N--CA 1.51 3.582 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.421 ' HB3' ' CB ' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.86 137.92 44.05 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 117.601 0.701 . . . . 0.0 110.297 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.65 111.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 CA-C-O 121.221 0.534 . . . . 0.0 111.191 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' A' ' 423' ' ' ASP . 3.6 mm? -106.03 118.69 37.27 Favored 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -62.56 -25.67 68.18 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.948 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.22 2.41 13.25 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.929 -0.482 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.52 8.18 46.92 Favored Glycine 0 N--CA 1.511 3.674 0 O-C-N 121.122 -0.986 . . . . 0.0 110.816 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 17.2 t80 71.2 148.05 0.08 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.18 0.99 . . . . 0.0 113.218 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.29 -56.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.704 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 407' ' ' CYS . 9.3 t -173.72 -125.14 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.494 HG21 ' HG2' ' A' ' 426' ' ' GLU . 18.2 m -78.37 124.39 28.05 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.912 -1.118 . . . . 0.0 108.474 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.483 ' HB2' HD22 ' A' ' 415' ' ' LEU . 19.3 m-20 -144.22 -54.67 0.35 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.436 -0.165 . . . . 0.0 111.283 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.5 pt -85.56 -29.85 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.801 0 O-C-N 121.869 -0.52 . . . . 0.0 111.556 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -114.6 73.49 0.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.494 ' HG2' HG21 ' A' ' 422' ' ' THR . 1.8 mt-10 . . . . . 0 N--CA 1.51 2.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.04 0.447 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -120.25 160.98 21.88 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.304 0.573 . . . . 0.0 110.955 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -84.24 116.6 65.7 Favored Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 36.4 Cg_endo -74.87 -168.24 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 123.324 2.683 . . . . 0.0 112.91 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 131.58 51.4 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.3 89.13 Favored Glycine 0 N--CA 1.511 3.67 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.51 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -111.87 137.69 49.5 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.344 1.072 . . . . 0.0 109.875 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.5 tp -171.4 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 CA-C-O 121.216 0.532 . . . . 0.0 110.359 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.6 mm? -100.74 112.03 24.37 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.388 0.613 . . . . 0.0 109.386 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.28 -26.29 68.71 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.008 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.38 -26.72 66.86 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 122.244 -0.285 . . . . 0.0 111.203 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.01 -28.93 2.47 Favored Glycine 0 N--CA 1.51 3.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.437 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 18.2 t80 75.01 148.35 0.1 Allowed 'General case' 0 N--CA 1.51 2.545 0 CA-C-O 122.04 0.924 . . . . 0.0 112.706 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 -60.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.711 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.4 t 178.9 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.508 HG21 ' HG2' ' A' ' 426' ' ' GLU . 7.0 m 70.29 122.46 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.063 0.545 . . . . 0.0 109.961 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.489 ' HB2' HD22 ' A' ' 415' ' ' LEU . 12.4 m-20 -148.68 -52.22 0.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.224 -0.298 . . . . 0.0 111.331 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.6 pt -85.02 -28.41 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 O-C-N 121.996 -0.44 . . . . 0.0 111.824 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.56 73.85 0.84 Allowed 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.508 ' HG2' HG21 ' A' ' 422' ' ' THR . 3.8 mt-10 . . . . . 0 N--CA 1.511 2.605 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 66.15 151.18 0.06 Allowed 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.712 0.767 . . . . 0.0 112.404 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 413' ' ' TYR . . . -114.39 132.64 22.71 Favored Pre-proline 0 N--CA 1.507 2.395 0 O-C-N 121.925 -0.484 . . . . 0.0 110.449 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.03 -176.81 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 123.042 2.495 . . . . 0.0 112.202 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.62 131.2 49.24 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 122.014 -0.429 . . . . 0.0 110.298 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.64 -23.94 30.18 Favored Glycine 0 N--CA 1.51 3.628 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.434 ' HB3' ' CB ' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -75.55 138.03 41.23 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 118.022 0.911 . . . . 0.0 110.368 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.01 111.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-O 121.121 0.486 . . . . 0.0 111.014 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.503 HD22 ' HB2' ' A' ' 423' ' ' ASP . 3.5 mm? -105.01 118.66 37.09 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.92 -25.4 68.31 Favored 'General case' 0 N--CA 1.518 2.961 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.876 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.28 0.45 16.59 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.992 -0.442 . . . . 0.0 111.958 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.43 5.49 42.68 Favored Glycine 0 N--CA 1.511 3.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.423 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 23.1 t80 70.97 146.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.38 1.086 . . . . 0.0 113.405 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 -59.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.324 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 4.9 t -168.18 -131.07 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.9 m -76.11 120.71 21.78 Favored 'General case' 0 N--CA 1.512 2.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.441 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.503 ' HB2' HD22 ' A' ' 415' ' ' LEU . 20.8 m-20 -139.34 -60.54 0.56 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.459 -0.151 . . . . 0.0 110.934 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.1 pt -72.37 -29.09 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 122.082 -0.386 . . . . 0.0 110.86 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.16 58.59 0.65 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.514 2.729 0 C-N-CA 123.192 0.597 . . . . 0.0 110.222 -179.408 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 121.02 0.438 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.75 161.1 28.11 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.317 0.58 . . . . 0.0 110.894 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -87.4 118.19 69.56 Favored Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 33.7 Cg_endo -72.15 -174.76 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.276 2.651 . . . . 0.0 112.978 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.67 125.85 24.11 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.373 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.08 -36.74 3.66 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.9 135.66 45.13 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.415 -0.462 . . . . 0.0 109.991 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -170.21 102.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 CA-C-O 121.214 0.531 . . . . 0.0 110.665 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -96.19 113.2 24.78 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.13 -26.36 67.63 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 122.134 -0.354 . . . . 0.0 111.223 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.55 2.32 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.414 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 24.0 t80 74.82 147.83 0.09 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 122.213 1.006 . . . . 0.0 112.818 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.01 -60.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.243 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.2 t 177.26 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 68.1 m 65.16 107.1 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 120.973 0.416 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.441 ' HB2' HD22 ' A' ' 415' ' ' LEU . 17.9 m-20 -144.19 -39.49 0.29 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.6 pt -102.54 -23.49 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.66 64.37 1.11 Allowed 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 119.29 0.95 . . . . 0.0 111.005 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.508 2.43 0 O-C-N 121.943 -0.473 . . . . 0.0 110.369 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.98 142.12 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 123.691 0.797 . . . . 0.0 111.81 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 413' ' ' TYR . . . -89.65 124.89 62.91 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.798 -0.564 . . . . 0.0 109.693 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.5 Cg_endo -70.37 -178.0 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.234 2.622 . . . . 0.0 113.169 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.61 125.6 22.94 Favored 'General case' 0 N--CA 1.517 2.889 0 CA-C-O 120.965 0.412 . . . . 0.0 110.375 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.53 -37.48 3.4 Favored Glycine 0 N--CA 1.51 3.617 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.54 137.34 44.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.978 0.511 . . . . 0.0 110.076 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.8 tp -173.22 107.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.601 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 423' ' ' ASP . 4.5 mm? -102.26 111.17 23.35 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.26 -25.85 68.51 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.09 -26.86 66.53 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.09 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.51 -32.87 1.71 Allowed Glycine 0 N--CA 1.51 3.593 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.428 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 26.2 t80 72.67 148.84 0.09 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 122.006 0.907 . . . . 0.0 112.617 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -62.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.927 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 17.4 t -179.4 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.421 ' CG2' ' HG2' ' A' ' 426' ' ' GLU . 7.2 m 70.73 121.65 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.001 0.52 . . . . 0.0 109.657 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ASP . . . . . 0.446 ' HB2' HD22 ' A' ' 415' ' ' LEU . 7.5 m-20 -145.99 -55.89 0.29 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.12 -0.362 . . . . 0.0 111.066 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.3 pt -81.21 -29.17 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.03 69.13 0.93 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.822 0.82 . . . . 0.0 108.834 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.421 ' HG2' ' CG2' ' A' ' 422' ' ' THR . 15.8 mt-10 . . . . . 0 N--CA 1.511 2.616 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.502 2.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 35.7 Cg_endo -74.79 -171.8 1.06 Allowed 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 123.192 2.595 . . . . 0.0 112.801 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.64 127.64 33.19 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.2 5.73 Favored Glycine 0 N--CA 1.51 3.627 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.883 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -75.54 133.81 40.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 122.854 0.461 . . . . 0.0 110.024 179.191 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.865 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.72 123.51 50.04 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.696 0.76 . . . . 0.0 109.525 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.19 -23.2 67.23 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.443 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -19.38 65.78 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 118.541 0.609 . . . . 0.0 111.177 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 123.55 -11.05 8.5 Favored Glycine 0 N--CA 1.506 3.346 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 11.2 t80 77.11 147.15 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 118.123 0.962 . . . . 0.0 111.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.85 -63.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.457 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 27.2 t 177.68 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.2 m 69.84 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 122.943 0.497 . . . . 0.0 109.689 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -148.12 -53.48 0.19 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.054 -0.404 . . . . 0.0 111.243 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.96 -32.91 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.368 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ASP . . . . . 0.414 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 16.2 m-20 . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.7 Cg_endo -71.11 -176.46 1.87 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 123.239 2.626 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.19 125.55 22.25 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 120.941 0.4 . . . . 0.0 110.384 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.91 -37.97 3.26 Favored Glycine 0 N--CA 1.51 3.624 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.748 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.17 136.86 46.58 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 122.926 0.49 . . . . 0.0 109.819 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 3.0 tp -169.71 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 CA-C-O 121.147 0.499 . . . . 0.0 110.622 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.444 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.5 mm? -101.77 110.61 22.63 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.366 0.603 . . . . 0.0 109.445 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -25.74 68.3 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.804 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.88 -27.41 66.67 Favored 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 122.396 0.278 . . . . 0.0 111.173 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 141.58 -31.43 2.13 Favored Glycine 0 N--CA 1.512 3.722 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.444 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 17.4 t80 75.14 148.83 0.1 Allowed 'General case' 0 N--CA 1.51 2.555 0 CA-C-O 122.116 0.96 . . . . 0.0 112.745 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.86 -59.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.65 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.9 t 178.13 96.12 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.2 m 70.21 122.66 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.145 0.578 . . . . 0.0 110.082 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.75 -60.68 0.33 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.075 -0.391 . . . . 0.0 111.031 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.91 -32.23 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 O-C-N 122.233 -0.292 . . . . 0.0 111.137 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.126 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.809 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.76 -177.19 2.07 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 123.165 2.576 . . . . 0.0 113.096 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.6 125.75 23.6 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.342 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.66 -36.99 3.54 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.809 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.26 136.29 44.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.403 -0.469 . . . . 0.0 110.013 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.9 tp -171.1 104.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.111 0.481 . . . . 0.0 110.675 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -98.53 112.55 24.55 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.26 -28.84 69.46 Favored 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.54 -31.66 68.16 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.299 -0.251 . . . . 0.0 110.942 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 147.36 -31.45 1.41 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.1 t80 75.03 147.25 0.09 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.277 1.037 . . . . 0.0 113.098 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.18 -63.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.5 t -179.49 105.94 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 67.16 116.53 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.558 0.694 . . . . 0.0 110.231 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -149.76 -60.91 0.21 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.849 -0.532 . . . . 0.0 111.128 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.511 HG23 HD21 ' A' ' 415' ' ' LEU . 5.9 pt -75.9 -36.76 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 O-C-N 122.191 -0.318 . . . . 0.0 111.765 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.227 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -70.83 -177.62 2.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.164 2.576 . . . . 0.0 113.161 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.42 125.78 23.52 Favored 'General case' 0 N--CA 1.516 2.838 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.458 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.45 -37.09 3.5 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.805 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.07 136.04 44.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.353 -0.498 . . . . 0.0 110.012 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.68 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 CA-C-O 121.188 0.518 . . . . 0.0 110.519 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.556 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -99.59 112.08 24.34 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.23 -27.36 67.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 122.247 -0.283 . . . . 0.0 111.118 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.96 -33.41 1.63 Allowed Glycine 0 N--CA 1.511 3.669 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 29.1 t80 73.05 147.64 0.09 Allowed 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.15 0.976 . . . . 0.0 113.015 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 -63.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.42 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.8 m 70.02 118.61 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 122.989 0.516 . . . . 0.0 109.888 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ASP . . . . . 0.414 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 11.8 m-20 -148.28 -54.79 0.2 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.226 -0.296 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.556 HG23 HD21 ' A' ' 415' ' ' LEU . 6.6 pt -81.39 -29.4 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.502 2.154 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.377 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.766 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -71.86 -173.92 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.293 2.662 . . . . 0.0 113.319 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.21 125.3 20.08 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-O 120.966 0.413 . . . . 0.0 110.459 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.01 -34.49 4.76 Favored Glycine 0 N--CA 1.509 3.553 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.766 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -74.33 134.07 42.54 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 117.17 0.485 . . . . 0.0 110.225 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -172.38 102.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -96.79 112.99 24.51 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.65 -26.94 68.89 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.97 -26.88 67.87 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 122.208 -0.307 . . . . 0.0 111.17 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.07 -33.39 1.72 Allowed Glycine 0 N--CA 1.51 3.613 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.445 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.4 t80 73.72 147.62 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.193 0.997 . . . . 0.0 113.139 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 -61.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.282 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 7.5 t 179.5 110.88 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.5 m 64.49 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 120.999 0.428 . . . . 0.0 109.914 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ASP . . . . . 0.432 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 13.2 m-20 -142.25 -37.13 0.4 Allowed 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.615 HG23 HD21 ' A' ' 415' ' ' LEU . 7.2 pt -105.61 -24.36 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.511 2.581 0 CA-C-N 119.222 0.919 . . . . 0.0 111.0 -178.827 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.4 Cg_endo -70.95 -176.38 1.79 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.218 2.612 . . . . 0.0 113.163 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.24 125.43 21.76 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.54 -37.53 3.38 Favored Glycine 0 N--CA 1.511 3.645 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.776 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.98 136.75 45.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 122.859 0.464 . . . . 0.0 109.997 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.6 103.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.789 0 CA-C-O 121.231 0.539 . . . . 0.0 111.224 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -101.02 104.31 15.45 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.34 -20.49 66.42 Favored 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 122.022 -0.424 . . . . 0.0 110.564 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 152.63 -39.95 0.73 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.466 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 31.7 t80 71.82 147.92 0.08 Allowed 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 122.332 1.063 . . . . 0.0 113.144 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.13 -62.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.7 t 178.48 112.68 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 83.9 m 66.24 103.93 0.04 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ASP . . . . . 0.428 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 10.7 m-20 -143.05 -39.2 0.33 Allowed 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 415' ' ' LEU . 7.8 pt -104.1 -24.17 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.51 2.553 0 CA-C-N 119.271 0.941 . . . . 0.0 111.068 -178.776 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.502 2.142 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -72.2 -172.26 0.85 Allowed 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 123.267 2.645 . . . . 0.0 113.112 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.06 128.83 39.18 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-O 121.0 0.429 . . . . 0.0 110.288 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 84.22 -5.38 80.51 Favored Glycine 0 N--CA 1.512 3.718 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.805 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -104.86 138.73 40.66 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 118.22 1.01 . . . . 0.0 109.705 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.4 tp -172.35 105.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 CA-C-O 121.173 0.511 . . . . 0.0 110.902 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -103.67 102.96 12.83 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.02 -19.76 65.96 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.14 -27.75 69.29 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 122.019 -0.426 . . . . 0.0 110.518 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 155.1 -41.58 0.6 Allowed Glycine 0 N--CA 1.511 3.655 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.479 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 34.2 t80 70.88 148.11 0.08 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.233 1.016 . . . . 0.0 113.079 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.78 -63.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.9 t -177.84 101.27 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.4 m 70.85 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.131 0 C-N-CA 123.01 0.524 . . . . 0.0 109.693 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ASP . . . . . 0.434 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 8.9 m-20 -147.84 -54.12 0.21 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.19 -0.319 . . . . 0.0 111.148 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 415' ' ' LEU . 6.6 pt -81.44 -29.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 O-C-N 122.105 -0.372 . . . . 0.0 111.941 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.431 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.918 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.86 -171.96 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.088 2.525 . . . . 0.0 112.172 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.82 129.27 41.3 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 122.024 -0.423 . . . . 0.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.99 -30.26 8.78 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.918 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -76.42 135.05 39.44 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 117.528 0.664 . . . . 0.0 110.009 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -165.88 112.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-O 121.051 0.453 . . . . 0.0 111.136 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.463 ' CD2' ' HB2' ' A' ' 423' ' ' ASP . 0.4 OUTLIER -111.14 122.81 48.82 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.535 0.683 . . . . 0.0 109.778 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.33 -23.93 67.14 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.877 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -15.69 63.63 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-N 118.357 0.526 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 119.87 -4.97 12.75 Favored Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 17.9 t80 77.68 146.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.206 1.003 . . . . 0.0 112.687 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 420' ' ' ILE . 0.1 OUTLIER -140.92 -57.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.537 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 6.6 t -171.14 -132.61 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.875 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 80.3 m -72.12 107.72 4.94 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.778 -1.202 . . . . 0.0 107.884 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ASP . . . . . 0.463 ' HB2' ' CD2' ' A' ' 415' ' ' LEU . 4.3 m-20 -125.41 -30.85 3.08 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.79 -11.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 CA-C-N 118.965 0.802 . . . . 0.0 112.671 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.506 2.333 0 CA-C-N 119.283 0.947 . . . . 0.0 110.81 -179.64 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.947 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 110.505 -0.184 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.79 -177.94 3.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.965 2.443 . . . . 0.0 112.285 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 130.76 48.13 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 121.988 -0.445 . . . . 0.0 110.301 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.71 -28.32 12.85 Favored Glycine 0 N--CA 1.511 3.673 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.947 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.05 137.31 45.24 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 117.811 0.805 . . . . 0.0 110.185 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.8 tp -161.9 111.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-O 121.168 0.509 . . . . 0.0 110.888 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.7 mm? -104.67 116.96 32.94 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -25.95 68.49 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.85 -9.36 57.43 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 122.038 -0.414 . . . . 0.0 111.851 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 117.45 -3.91 17.86 Favored Glycine 0 N--CA 1.512 3.73 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.718 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 24.1 t80 73.56 146.28 0.08 Allowed 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.252 1.025 . . . . 0.0 113.21 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -59.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.151 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 5.5 t -166.98 -129.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.1 t -75.17 131.73 40.65 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 119.842 1.201 . . . . 0.0 108.938 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ASP . . . . . 0.814 ' HB2' HD21 ' A' ' 415' ' ' LEU . 17.1 m-20 -145.61 -55.02 0.29 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.553 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.9 pt -84.56 -32.89 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 O-C-N 122.015 -0.428 . . . . 0.0 111.285 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 N--CA 1.505 2.311 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.85 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.951 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.507 2.416 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.09 -174.57 2.13 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.961 2.44 . . . . 0.0 112.146 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.54 129.8 43.75 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 122.015 -0.428 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.89 -29.29 10.12 Favored Glycine 0 N--CA 1.51 3.582 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.951 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.86 137.92 44.05 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 117.601 0.701 . . . . 0.0 110.297 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.65 111.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 CA-C-O 121.221 0.534 . . . . 0.0 111.191 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.879 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.6 mm? -106.03 118.69 37.27 Favored 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -62.56 -25.67 68.18 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.948 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.22 2.41 13.25 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.929 -0.482 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.52 8.18 46.92 Favored Glycine 0 N--CA 1.511 3.674 0 O-C-N 121.122 -0.986 . . . . 0.0 110.816 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.75 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 17.2 t80 71.2 148.05 0.08 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.18 0.99 . . . . 0.0 113.218 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.29 -56.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.704 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.3 t -173.72 -125.14 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.2 m -78.37 124.39 28.05 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.912 -1.118 . . . . 0.0 108.474 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ASP . . . . . 0.879 ' HB2' HD21 ' A' ' 415' ' ' LEU . 19.3 m-20 -144.22 -54.67 0.35 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.436 -0.165 . . . . 0.0 111.283 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 413' ' ' TYR . 4.5 pt -85.56 -29.85 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.801 0 O-C-N 121.869 -0.52 . . . . 0.0 111.556 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ASP . . . . . 0.406 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 14.8 m-20 . . . . . 0 N--CA 1.504 2.263 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 36.4 Cg_endo -74.87 -168.24 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 123.324 2.683 . . . . 0.0 112.91 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 131.58 51.4 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.3 89.13 Favored Glycine 0 N--CA 1.511 3.67 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -111.87 137.69 49.5 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.344 1.072 . . . . 0.0 109.875 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.5 tp -171.4 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 CA-C-O 121.216 0.532 . . . . 0.0 110.359 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -100.74 112.03 24.37 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.388 0.613 . . . . 0.0 109.386 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.28 -26.29 68.71 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.008 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.38 -26.72 66.86 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 122.244 -0.285 . . . . 0.0 111.203 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.01 -28.93 2.47 Favored Glycine 0 N--CA 1.51 3.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.448 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 18.2 t80 75.01 148.35 0.1 Allowed 'General case' 0 N--CA 1.51 2.545 0 CA-C-O 122.04 0.924 . . . . 0.0 112.706 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 420' ' ' ILE . 0.1 OUTLIER -143.77 -60.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.711 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.4 t 178.9 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 m 70.29 122.46 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.063 0.545 . . . . 0.0 109.961 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -148.68 -52.22 0.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.224 -0.298 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.465 HG23 HD21 ' A' ' 415' ' ' LEU . 5.6 pt -85.02 -28.41 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 O-C-N 121.996 -0.44 . . . . 0.0 111.824 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.503 2.199 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.205 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.972 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.507 2.395 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.03 -176.81 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 123.042 2.495 . . . . 0.0 112.202 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.62 131.2 49.24 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 122.014 -0.429 . . . . 0.0 110.298 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.64 -23.94 30.18 Favored Glycine 0 N--CA 1.51 3.628 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.972 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -75.55 138.03 41.23 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 118.022 0.911 . . . . 0.0 110.368 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.01 111.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-O 121.121 0.486 . . . . 0.0 111.014 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.5 mm? -105.01 118.66 37.09 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.92 -25.4 68.31 Favored 'General case' 0 N--CA 1.518 2.961 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.876 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.28 0.45 16.59 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.992 -0.442 . . . . 0.0 111.958 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.43 5.49 42.68 Favored Glycine 0 N--CA 1.511 3.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.757 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 23.1 t80 70.97 146.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.38 1.086 . . . . 0.0 113.405 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 -59.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.324 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 4.9 t -168.18 -131.07 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.9 m -76.11 120.71 21.78 Favored 'General case' 0 N--CA 1.512 2.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.441 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' ASP . . . . . 0.857 ' HB2' HD21 ' A' ' 415' ' ' LEU . 20.8 m-20 -139.34 -60.54 0.56 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.459 -0.151 . . . . 0.0 110.934 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 413' ' ' TYR . 5.1 pt -72.37 -29.09 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 122.082 -0.386 . . . . 0.0 110.86 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.502 2.152 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.043 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.786 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 33.7 Cg_endo -72.15 -174.76 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.276 2.651 . . . . 0.0 112.978 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.67 125.85 24.11 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.373 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.08 -36.74 3.66 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.786 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.9 135.66 45.13 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.415 -0.462 . . . . 0.0 109.991 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -170.21 102.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 CA-C-O 121.214 0.531 . . . . 0.0 110.665 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -96.19 113.2 24.78 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.13 -26.36 67.63 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 122.134 -0.354 . . . . 0.0 111.223 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.55 2.32 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.421 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 24.0 t80 74.82 147.83 0.09 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 122.213 1.006 . . . . 0.0 112.818 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 420' ' ' ILE . 0.1 OUTLIER -144.01 -60.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.243 179.159 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.2 t 177.26 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 68.1 m 65.16 107.1 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 120.973 0.416 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -144.19 -39.49 0.29 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.517 HG23 HD21 ' A' ' 415' ' ' LEU . 7.6 pt -102.54 -23.49 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.511 2.596 0 CA-C-N 119.29 0.95 . . . . 0.0 111.005 -178.76 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 409' ' ' ALA . . . . . 0.752 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.238 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.5 Cg_endo -70.37 -178.0 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.234 2.622 . . . . 0.0 113.169 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.61 125.6 22.94 Favored 'General case' 0 N--CA 1.517 2.889 0 CA-C-O 120.965 0.412 . . . . 0.0 110.375 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.53 -37.48 3.4 Favored Glycine 0 N--CA 1.51 3.617 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.752 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.54 137.34 44.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.978 0.511 . . . . 0.0 110.076 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.8 tp -173.22 107.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.601 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -102.26 111.17 23.35 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.26 -25.85 68.51 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.09 -26.86 66.53 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.09 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.51 -32.87 1.71 Allowed Glycine 0 N--CA 1.51 3.593 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' PHE . . . . . 0.437 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 26.2 t80 72.67 148.84 0.09 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 122.006 0.907 . . . . 0.0 112.617 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -62.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.927 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 17.4 t -179.4 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.2 m 70.73 121.65 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.001 0.52 . . . . 0.0 109.657 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -145.99 -55.89 0.29 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.12 -0.362 . . . . 0.0 111.066 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 415' ' ' LEU . 7.3 pt -81.21 -29.17 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.504 2.23 0 CA-C-O 121.822 0.82 . . . . 0.0 108.834 179.742 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 407' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 420' ' ' ILE . 33.4 m . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.335 0.588 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -120.44 160.7 22.58 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.333 0.587 . . . . 0.0 111.316 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -109.24 115.17 56.96 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 35.7 Cg_endo -74.79 -171.8 1.06 Allowed 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 123.192 2.595 . . . . 0.0 112.801 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.64 127.64 33.19 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.2 5.73 Favored Glycine 0 N--CA 1.51 3.627 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.883 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -75.54 133.81 40.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 122.854 0.461 . . . . 0.0 110.024 179.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.865 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.72 123.51 50.04 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.696 0.76 . . . . 0.0 109.525 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.19 -23.2 67.23 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.443 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -19.38 65.78 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 118.541 0.609 . . . . 0.0 111.177 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 123.55 -11.05 8.5 Favored Glycine 0 N--CA 1.506 3.346 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 11.2 t80 77.11 147.15 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 118.123 0.962 . . . . 0.0 111.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 407' ' ' CYS . 0.1 OUTLIER -138.85 -63.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.457 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 407' ' ' CYS . 27.2 t 177.68 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.713 HG22 ' HG2' ' A' ' 426' ' ' GLU . 7.2 m 69.84 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 122.943 0.497 . . . . 0.0 109.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -148.12 -53.48 0.19 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.054 -0.404 . . . . 0.0 111.243 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.96 -32.91 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.368 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ASP . . . . . 0.414 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 16.2 m-20 -112.3 72.69 0.78 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.713 ' HG2' HG22 ' A' ' 422' ' ' THR . 2.0 mt-10 . . . . . 0 N--CA 1.51 2.568 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 121.049 0.452 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.09 159.03 23.93 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 121.213 0.53 . . . . 0.0 110.913 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -83.15 120.18 75.45 Favored Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.7 Cg_endo -71.11 -176.46 1.87 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 123.239 2.626 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.19 125.55 22.25 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 120.941 0.4 . . . . 0.0 110.384 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.91 -37.97 3.26 Favored Glycine 0 N--CA 1.51 3.624 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.748 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.17 136.86 46.58 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 122.926 0.49 . . . . 0.0 109.819 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 3.0 tp -169.71 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 CA-C-O 121.147 0.499 . . . . 0.0 110.622 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.444 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.5 mm? -101.77 110.61 22.63 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.366 0.603 . . . . 0.0 109.445 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -25.74 68.3 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.804 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.88 -27.41 66.67 Favored 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 122.396 0.278 . . . . 0.0 111.173 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 141.58 -31.43 2.13 Favored Glycine 0 N--CA 1.512 3.722 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.444 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 17.4 t80 75.14 148.83 0.1 Allowed 'General case' 0 N--CA 1.51 2.555 0 CA-C-O 122.116 0.96 . . . . 0.0 112.745 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.86 -59.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.65 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.9 t 178.13 96.12 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.2 m 70.21 122.66 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.145 0.578 . . . . 0.0 110.082 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.75 -60.68 0.33 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.075 -0.391 . . . . 0.0 111.031 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.91 -32.23 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 O-C-N 122.233 -0.292 . . . . 0.0 111.137 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.64 62.12 0.71 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.512 2.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 -179.19 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.6 148.27 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 CA-C-O 121.822 0.82 . . . . 0.0 112.261 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.809 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -91.41 124.48 61.02 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.853 -0.529 . . . . 0.0 109.818 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.76 -177.19 2.07 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 123.165 2.576 . . . . 0.0 113.096 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.6 125.75 23.6 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.342 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.66 -36.99 3.54 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.809 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.26 136.29 44.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.403 -0.469 . . . . 0.0 110.013 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.9 tp -171.1 104.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.111 0.481 . . . . 0.0 110.675 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -98.53 112.55 24.55 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.26 -28.84 69.46 Favored 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.54 -31.66 68.16 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.299 -0.251 . . . . 0.0 110.942 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 147.36 -31.45 1.41 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.1 t80 75.03 147.25 0.09 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.277 1.037 . . . . 0.0 113.098 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.18 -63.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.5 t -179.49 105.94 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 67.16 116.53 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.558 0.694 . . . . 0.0 110.231 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -149.76 -60.91 0.21 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.849 -0.532 . . . . 0.0 111.128 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.511 HG23 HD21 ' A' ' 415' ' ' LEU . 5.9 pt -75.9 -36.76 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 O-C-N 122.191 -0.318 . . . . 0.0 111.765 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.65 65.63 0.77 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.508 2.437 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.761 -178.905 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.41 150.58 0.06 Allowed 'General case' 0 N--CA 1.517 2.88 0 CA-C-O 121.809 0.814 . . . . 0.0 112.308 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -93.95 125.84 51.44 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.902 -0.499 . . . . 0.0 109.864 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -70.83 -177.62 2.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.164 2.576 . . . . 0.0 113.161 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.42 125.78 23.52 Favored 'General case' 0 N--CA 1.516 2.838 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.458 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.45 -37.09 3.5 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.805 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.07 136.04 44.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.353 -0.498 . . . . 0.0 110.012 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.68 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 CA-C-O 121.188 0.518 . . . . 0.0 110.519 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.556 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -99.59 112.08 24.34 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.23 -27.36 67.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 122.247 -0.283 . . . . 0.0 111.118 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.96 -33.41 1.63 Allowed Glycine 0 N--CA 1.511 3.669 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 29.1 t80 73.05 147.64 0.09 Allowed 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.15 0.976 . . . . 0.0 113.015 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 -63.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.42 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 426' ' ' GLU . 6.8 m 70.02 118.61 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 122.989 0.516 . . . . 0.0 109.888 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ASP . . . . . 0.414 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 11.8 m-20 -148.28 -54.79 0.2 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.226 -0.296 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.556 HG23 HD21 ' A' ' 415' ' ' LEU . 6.6 pt -81.39 -29.4 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.7 71.28 0.85 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.781 ' HG2' HG22 ' A' ' 422' ' ' THR . 11.8 mt-10 . . . . . 0 N--CA 1.512 2.649 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.379 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.72 174.25 10.82 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 121.439 0.638 . . . . 0.0 111.42 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.766 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -108.52 112.89 60.57 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -71.86 -173.92 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.293 2.662 . . . . 0.0 113.319 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.21 125.3 20.08 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-O 120.966 0.413 . . . . 0.0 110.459 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.01 -34.49 4.76 Favored Glycine 0 N--CA 1.509 3.553 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.766 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -74.33 134.07 42.54 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 117.17 0.485 . . . . 0.0 110.225 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -172.38 102.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -96.79 112.99 24.51 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.65 -26.94 68.89 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.97 -26.88 67.87 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 122.208 -0.307 . . . . 0.0 111.17 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.07 -33.39 1.72 Allowed Glycine 0 N--CA 1.51 3.613 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.445 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.4 t80 73.72 147.62 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.193 0.997 . . . . 0.0 113.139 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 -61.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.282 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 7.5 t 179.5 110.88 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.415 HG22 ' CD ' ' A' ' 426' ' ' GLU . 86.5 m 64.49 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 120.999 0.428 . . . . 0.0 109.914 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ASP . . . . . 0.432 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 13.2 m-20 -142.25 -37.13 0.4 Allowed 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.615 HG23 HD21 ' A' ' 415' ' ' LEU . 7.2 pt -105.61 -24.36 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.91 64.81 1.26 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 119.222 0.919 . . . . 0.0 111.0 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.415 ' CD ' HG22 ' A' ' 422' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.507 2.393 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.386 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.27 150.65 0.05 Allowed 'General case' 0 N--CA 1.516 2.857 0 CA-C-O 121.742 0.782 . . . . 0.0 112.264 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -91.57 122.45 65.77 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 121.871 -0.518 . . . . 0.0 109.764 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.4 Cg_endo -70.95 -176.38 1.79 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.218 2.612 . . . . 0.0 113.163 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.24 125.43 21.76 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.54 -37.53 3.38 Favored Glycine 0 N--CA 1.511 3.645 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.776 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.98 136.75 45.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 122.859 0.464 . . . . 0.0 109.997 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.6 103.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.789 0 CA-C-O 121.231 0.539 . . . . 0.0 111.224 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -101.02 104.31 15.45 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.34 -20.49 66.42 Favored 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 122.022 -0.424 . . . . 0.0 110.564 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 152.63 -39.95 0.73 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.466 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 31.7 t80 71.82 147.92 0.08 Allowed 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 122.332 1.063 . . . . 0.0 113.144 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.13 -62.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.7 t 178.48 112.68 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.415 HG22 ' CD ' ' A' ' 426' ' ' GLU . 83.9 m 66.24 103.93 0.04 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ASP . . . . . 0.428 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 10.7 m-20 -143.05 -39.2 0.33 Allowed 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 415' ' ' LEU . 7.8 pt -104.1 -24.17 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.67 64.36 1.28 Allowed 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 119.271 0.941 . . . . 0.0 111.068 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.415 ' CD ' HG22 ' A' ' 422' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.506 2.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.383 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.32 154.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 121.896 0.855 . . . . 0.0 112.774 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -92.8 122.51 63.79 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -72.2 -172.26 0.85 Allowed 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 123.267 2.645 . . . . 0.0 113.112 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.06 128.83 39.18 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-O 121.0 0.429 . . . . 0.0 110.288 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 84.22 -5.38 80.51 Favored Glycine 0 N--CA 1.512 3.718 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.805 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -104.86 138.73 40.66 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 118.22 1.01 . . . . 0.0 109.705 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.4 tp -172.35 105.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 CA-C-O 121.173 0.511 . . . . 0.0 110.902 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -103.67 102.96 12.83 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.02 -19.76 65.96 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.14 -27.75 69.29 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 122.019 -0.426 . . . . 0.0 110.518 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 155.1 -41.58 0.6 Allowed Glycine 0 N--CA 1.511 3.655 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.479 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 34.2 t80 70.88 148.11 0.08 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.233 1.016 . . . . 0.0 113.079 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.78 -63.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.9 t -177.84 101.27 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 426' ' ' GLU . 7.4 m 70.85 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.131 0 C-N-CA 123.01 0.524 . . . . 0.0 109.693 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ASP . . . . . 0.434 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 8.9 m-20 -147.84 -54.12 0.21 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.19 -0.319 . . . . 0.0 111.148 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 415' ' ' LEU . 6.6 pt -81.44 -29.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 O-C-N 122.105 -0.372 . . . . 0.0 111.941 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.83 71.16 0.83 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.778 ' HG2' HG22 ' A' ' 422' ' ' THR . 10.7 mt-10 . . . . . 0 N--CA 1.512 2.637 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.417 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 6.0 m . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.36 161.29 25.0 Favored 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.337 0.589 . . . . 0.0 111.164 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.918 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -105.5 116.36 60.29 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 122.09 -0.381 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.86 -171.96 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.088 2.525 . . . . 0.0 112.172 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.82 129.27 41.3 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 122.024 -0.423 . . . . 0.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.99 -30.26 8.78 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.918 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -76.42 135.05 39.44 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 117.528 0.664 . . . . 0.0 110.009 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -165.88 112.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-O 121.051 0.453 . . . . 0.0 111.136 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.463 ' CD2' ' HB2' ' A' ' 423' ' ' ASP . 0.4 OUTLIER -111.14 122.81 48.82 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.535 0.683 . . . . 0.0 109.778 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.33 -23.93 67.14 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.877 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -15.69 63.63 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-N 118.357 0.526 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 119.87 -4.97 12.75 Favored Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 17.9 t80 77.68 146.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.206 1.003 . . . . 0.0 112.687 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 420' ' ' ILE . 0.1 OUTLIER -140.92 -57.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.537 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 407' ' ' CYS . 6.6 t -171.14 -132.61 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.875 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 80.3 m -72.12 107.72 4.94 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.778 -1.202 . . . . 0.0 107.884 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ASP . . . . . 0.463 ' HB2' ' CD2' ' A' ' 415' ' ' LEU . 4.3 m-20 -125.41 -30.85 3.08 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.79 -11.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 CA-C-N 118.965 0.802 . . . . 0.0 112.671 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.96 75.5 1.01 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.283 0.947 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.51 2.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.233 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 65.93 153.63 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 CA-C-O 121.729 0.776 . . . . 0.0 112.482 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.947 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -114.56 133.49 22.5 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 121.916 -0.49 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.79 -177.94 3.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.965 2.443 . . . . 0.0 112.285 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 130.76 48.13 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 121.988 -0.445 . . . . 0.0 110.301 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.71 -28.32 12.85 Favored Glycine 0 N--CA 1.511 3.673 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.947 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.05 137.31 45.24 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 117.811 0.805 . . . . 0.0 110.185 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.8 tp -161.9 111.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-O 121.168 0.509 . . . . 0.0 110.888 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.7 mm? -104.67 116.96 32.94 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -25.95 68.49 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.85 -9.36 57.43 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 122.038 -0.414 . . . . 0.0 111.851 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 117.45 -3.91 17.86 Favored Glycine 0 N--CA 1.512 3.73 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.718 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 24.1 t80 73.56 146.28 0.08 Allowed 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.252 1.025 . . . . 0.0 113.21 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -59.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.151 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 5.5 t -166.98 -129.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.1 t -75.17 131.73 40.65 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 119.842 1.201 . . . . 0.0 108.938 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ASP . . . . . 0.814 ' HB2' HD21 ' A' ' 415' ' ' LEU . 17.1 m-20 -145.61 -55.02 0.29 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.553 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.9 pt -84.56 -32.89 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 O-C-N 122.015 -0.428 . . . . 0.0 111.285 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -115.23 71.7 0.77 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 N--CA 1.509 2.496 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.369 -179.356 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 407' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.725 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -122.14 151.1 41.3 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.951 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -99.99 120.82 55.94 Favored Pre-proline 0 N--CA 1.507 2.416 0 O-C-N 122.104 -0.372 . . . . 0.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.09 -174.57 2.13 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.961 2.44 . . . . 0.0 112.146 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.54 129.8 43.75 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 122.015 -0.428 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.89 -29.29 10.12 Favored Glycine 0 N--CA 1.51 3.582 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.951 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.86 137.92 44.05 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 117.601 0.701 . . . . 0.0 110.297 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.65 111.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 CA-C-O 121.221 0.534 . . . . 0.0 111.191 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.879 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.6 mm? -106.03 118.69 37.27 Favored 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -62.56 -25.67 68.18 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.948 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.22 2.41 13.25 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.929 -0.482 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.52 8.18 46.92 Favored Glycine 0 N--CA 1.511 3.674 0 O-C-N 121.122 -0.986 . . . . 0.0 110.816 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.75 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 17.2 t80 71.2 148.05 0.08 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.18 0.99 . . . . 0.0 113.218 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.29 -56.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.704 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 407' ' ' CYS . 9.3 t -173.72 -125.14 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.764 HG22 ' HG2' ' A' ' 426' ' ' GLU . 18.2 m -78.37 124.39 28.05 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.912 -1.118 . . . . 0.0 108.474 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ASP . . . . . 0.879 ' HB2' HD21 ' A' ' 415' ' ' LEU . 19.3 m-20 -144.22 -54.67 0.35 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.436 -0.165 . . . . 0.0 111.283 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 413' ' ' TYR . 4.5 pt -85.56 -29.85 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.801 0 O-C-N 121.869 -0.52 . . . . 0.0 111.556 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ASP . . . . . 0.406 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 14.8 m-20 -114.6 73.49 0.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.764 ' HG2' HG22 ' A' ' 422' ' ' THR . 1.8 mt-10 . . . . . 0 N--CA 1.51 2.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.04 0.447 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -120.25 160.98 21.88 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.304 0.573 . . . . 0.0 110.955 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -84.24 116.6 65.7 Favored Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 36.4 Cg_endo -74.87 -168.24 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 123.324 2.683 . . . . 0.0 112.91 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 131.58 51.4 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.3 89.13 Favored Glycine 0 N--CA 1.511 3.67 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -111.87 137.69 49.5 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.344 1.072 . . . . 0.0 109.875 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.5 tp -171.4 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 CA-C-O 121.216 0.532 . . . . 0.0 110.359 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -100.74 112.03 24.37 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.388 0.613 . . . . 0.0 109.386 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.28 -26.29 68.71 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.008 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.38 -26.72 66.86 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 122.244 -0.285 . . . . 0.0 111.203 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.01 -28.93 2.47 Favored Glycine 0 N--CA 1.51 3.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.448 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 18.2 t80 75.01 148.35 0.1 Allowed 'General case' 0 N--CA 1.51 2.545 0 CA-C-O 122.04 0.924 . . . . 0.0 112.706 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 420' ' ' ILE . 0.1 OUTLIER -143.77 -60.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.711 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.4 t 178.9 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.817 HG22 ' HG2' ' A' ' 426' ' ' GLU . 7.0 m 70.29 122.46 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.063 0.545 . . . . 0.0 109.961 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -148.68 -52.22 0.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.224 -0.298 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.465 HG23 HD21 ' A' ' 415' ' ' LEU . 5.6 pt -85.02 -28.41 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 O-C-N 121.996 -0.44 . . . . 0.0 111.824 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.56 73.85 0.84 Allowed 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.817 ' HG2' HG22 ' A' ' 422' ' ' THR . 3.8 mt-10 . . . . . 0 N--CA 1.511 2.605 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' CYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 1.1 m . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 66.15 151.18 0.06 Allowed 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.712 0.767 . . . . 0.0 112.404 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.972 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -114.39 132.64 22.71 Favored Pre-proline 0 N--CA 1.507 2.395 0 O-C-N 121.925 -0.484 . . . . 0.0 110.449 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.03 -176.81 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 123.042 2.495 . . . . 0.0 112.202 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.62 131.2 49.24 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 122.014 -0.429 . . . . 0.0 110.298 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.64 -23.94 30.18 Favored Glycine 0 N--CA 1.51 3.628 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.972 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -75.55 138.03 41.23 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 118.022 0.911 . . . . 0.0 110.368 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.01 111.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-O 121.121 0.486 . . . . 0.0 111.014 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.5 mm? -105.01 118.66 37.09 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.92 -25.4 68.31 Favored 'General case' 0 N--CA 1.518 2.961 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.876 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.28 0.45 16.59 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.992 -0.442 . . . . 0.0 111.958 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.43 5.49 42.68 Favored Glycine 0 N--CA 1.511 3.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.757 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 23.1 t80 70.97 146.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.38 1.086 . . . . 0.0 113.405 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 -59.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.324 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 407' ' ' CYS . 4.9 t -168.18 -131.07 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.9 m -76.11 120.71 21.78 Favored 'General case' 0 N--CA 1.512 2.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.441 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ASP . . . . . 0.857 ' HB2' HD21 ' A' ' 415' ' ' LEU . 20.8 m-20 -139.34 -60.54 0.56 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.459 -0.151 . . . . 0.0 110.934 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 413' ' ' TYR . 5.1 pt -72.37 -29.09 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 122.082 -0.386 . . . . 0.0 110.86 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.16 58.59 0.65 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.514 2.729 0 C-N-CA 123.192 0.597 . . . . 0.0 110.222 -179.408 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 121.02 0.438 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.75 161.1 28.11 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.317 0.58 . . . . 0.0 110.894 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.786 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -87.4 118.19 69.56 Favored Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 33.7 Cg_endo -72.15 -174.76 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.276 2.651 . . . . 0.0 112.978 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.67 125.85 24.11 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.373 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.08 -36.74 3.66 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.786 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.9 135.66 45.13 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.415 -0.462 . . . . 0.0 109.991 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -170.21 102.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 CA-C-O 121.214 0.531 . . . . 0.0 110.665 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -96.19 113.2 24.78 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.13 -26.36 67.63 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 122.134 -0.354 . . . . 0.0 111.223 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.55 2.32 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.421 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 24.0 t80 74.82 147.83 0.09 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 122.213 1.006 . . . . 0.0 112.818 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 420' ' ' ILE . 0.1 OUTLIER -144.01 -60.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.243 179.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.2 t 177.26 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.441 HG22 ' CD ' ' A' ' 426' ' ' GLU . 68.1 m 65.16 107.1 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 120.973 0.416 . . . . 0.0 110.028 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -144.19 -39.49 0.29 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.517 HG23 HD21 ' A' ' 415' ' ' LEU . 7.6 pt -102.54 -23.49 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.66 64.37 1.11 Allowed 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 119.29 0.95 . . . . 0.0 111.005 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.441 ' CD ' HG22 ' A' ' 422' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.508 2.43 0 O-C-N 121.943 -0.473 . . . . 0.0 110.369 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.98 142.12 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 123.691 0.797 . . . . 0.0 111.81 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' ALA . . . . . 0.752 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -89.65 124.89 62.91 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.798 -0.564 . . . . 0.0 109.693 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.5 Cg_endo -70.37 -178.0 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.234 2.622 . . . . 0.0 113.169 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.61 125.6 22.94 Favored 'General case' 0 N--CA 1.517 2.889 0 CA-C-O 120.965 0.412 . . . . 0.0 110.375 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.53 -37.48 3.4 Favored Glycine 0 N--CA 1.51 3.617 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.752 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.54 137.34 44.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.978 0.511 . . . . 0.0 110.076 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.8 tp -173.22 107.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.601 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -102.26 111.17 23.35 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.26 -25.85 68.51 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.09 -26.86 66.53 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.09 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.51 -32.87 1.71 Allowed Glycine 0 N--CA 1.51 3.593 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.437 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 26.2 t80 72.67 148.84 0.09 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 122.006 0.907 . . . . 0.0 112.617 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -62.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.927 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 17.4 t -179.4 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 426' ' ' GLU . 7.2 m 70.73 121.65 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.001 0.52 . . . . 0.0 109.657 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -145.99 -55.89 0.29 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.12 -0.362 . . . . 0.0 111.066 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 415' ' ' LEU . 7.3 pt -81.21 -29.17 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.03 69.13 0.93 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.822 0.82 . . . . 0.0 108.834 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' A' ' 422' ' ' THR . 15.8 mt-10 . . . . . 0 N--CA 1.511 2.616 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.502 2.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 35.7 Cg_endo -74.79 -171.8 1.06 Allowed 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 123.192 2.595 . . . . 0.0 112.801 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.64 127.64 33.19 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.2 5.73 Favored Glycine 0 N--CA 1.51 3.627 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.883 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -75.54 133.81 40.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 122.854 0.461 . . . . 0.0 110.024 179.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.865 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.72 123.51 50.04 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.696 0.76 . . . . 0.0 109.525 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.19 -23.2 67.23 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.443 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -19.38 65.78 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 118.541 0.609 . . . . 0.0 111.177 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 123.55 -11.05 8.5 Favored Glycine 0 N--CA 1.506 3.346 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 11.2 t80 77.11 147.15 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 118.123 0.962 . . . . 0.0 111.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.85 -63.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.457 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 27.2 t 177.68 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.2 m 69.84 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 122.943 0.497 . . . . 0.0 109.689 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -148.12 -53.48 0.19 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.054 -0.404 . . . . 0.0 111.243 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.96 -32.91 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.368 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . 0.414 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 16.2 m-20 . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.7 Cg_endo -71.11 -176.46 1.87 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 123.239 2.626 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.19 125.55 22.25 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 120.941 0.4 . . . . 0.0 110.384 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.91 -37.97 3.26 Favored Glycine 0 N--CA 1.51 3.624 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.748 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.17 136.86 46.58 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 122.926 0.49 . . . . 0.0 109.819 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 3.0 tp -169.71 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 CA-C-O 121.147 0.499 . . . . 0.0 110.622 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.444 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.5 mm? -101.77 110.61 22.63 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.366 0.603 . . . . 0.0 109.445 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -25.74 68.3 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.804 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.88 -27.41 66.67 Favored 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 122.396 0.278 . . . . 0.0 111.173 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 141.58 -31.43 2.13 Favored Glycine 0 N--CA 1.512 3.722 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.444 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 17.4 t80 75.14 148.83 0.1 Allowed 'General case' 0 N--CA 1.51 2.555 0 CA-C-O 122.116 0.96 . . . . 0.0 112.745 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.86 -59.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.65 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.9 t 178.13 96.12 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.2 m 70.21 122.66 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.145 0.578 . . . . 0.0 110.082 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.75 -60.68 0.33 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.075 -0.391 . . . . 0.0 111.031 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.91 -32.23 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 O-C-N 122.233 -0.292 . . . . 0.0 111.137 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.126 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.809 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.76 -177.19 2.07 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 123.165 2.576 . . . . 0.0 113.096 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.6 125.75 23.6 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.342 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.66 -36.99 3.54 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.809 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.26 136.29 44.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.403 -0.469 . . . . 0.0 110.013 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.9 tp -171.1 104.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.111 0.481 . . . . 0.0 110.675 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -98.53 112.55 24.55 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.26 -28.84 69.46 Favored 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.54 -31.66 68.16 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.299 -0.251 . . . . 0.0 110.942 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 147.36 -31.45 1.41 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.1 t80 75.03 147.25 0.09 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.277 1.037 . . . . 0.0 113.098 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.18 -63.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.5 t -179.49 105.94 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 67.16 116.53 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.558 0.694 . . . . 0.0 110.231 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -149.76 -60.91 0.21 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.849 -0.532 . . . . 0.0 111.128 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.511 HG23 HD21 ' A' ' 415' ' ' LEU . 5.9 pt -75.9 -36.76 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 O-C-N 122.191 -0.318 . . . . 0.0 111.765 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.227 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -70.83 -177.62 2.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.164 2.576 . . . . 0.0 113.161 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.42 125.78 23.52 Favored 'General case' 0 N--CA 1.516 2.838 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.458 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.45 -37.09 3.5 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.805 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.07 136.04 44.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.353 -0.498 . . . . 0.0 110.012 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.68 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 CA-C-O 121.188 0.518 . . . . 0.0 110.519 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.556 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -99.59 112.08 24.34 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.23 -27.36 67.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 122.247 -0.283 . . . . 0.0 111.118 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.96 -33.41 1.63 Allowed Glycine 0 N--CA 1.511 3.669 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 29.1 t80 73.05 147.64 0.09 Allowed 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.15 0.976 . . . . 0.0 113.015 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 -63.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.42 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.8 m 70.02 118.61 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 122.989 0.516 . . . . 0.0 109.888 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . 0.414 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 11.8 m-20 -148.28 -54.79 0.2 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.226 -0.296 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.556 HG23 HD21 ' A' ' 415' ' ' LEU . 6.6 pt -81.39 -29.4 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.502 2.154 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.377 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.766 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -71.86 -173.92 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.293 2.662 . . . . 0.0 113.319 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.21 125.3 20.08 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-O 120.966 0.413 . . . . 0.0 110.459 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.01 -34.49 4.76 Favored Glycine 0 N--CA 1.509 3.553 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.766 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -74.33 134.07 42.54 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 117.17 0.485 . . . . 0.0 110.225 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -172.38 102.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -96.79 112.99 24.51 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.65 -26.94 68.89 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.97 -26.88 67.87 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 122.208 -0.307 . . . . 0.0 111.17 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.07 -33.39 1.72 Allowed Glycine 0 N--CA 1.51 3.613 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.445 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.4 t80 73.72 147.62 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.193 0.997 . . . . 0.0 113.139 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 -61.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.282 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 7.5 t 179.5 110.88 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.5 m 64.49 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 120.999 0.428 . . . . 0.0 109.914 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . 0.432 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 13.2 m-20 -142.25 -37.13 0.4 Allowed 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.615 HG23 HD21 ' A' ' 415' ' ' LEU . 7.2 pt -105.61 -24.36 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.511 2.581 0 CA-C-N 119.222 0.919 . . . . 0.0 111.0 -178.827 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.4 Cg_endo -70.95 -176.38 1.79 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.218 2.612 . . . . 0.0 113.163 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.24 125.43 21.76 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.54 -37.53 3.38 Favored Glycine 0 N--CA 1.511 3.645 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.776 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.98 136.75 45.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 122.859 0.464 . . . . 0.0 109.997 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.6 103.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.789 0 CA-C-O 121.231 0.539 . . . . 0.0 111.224 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -101.02 104.31 15.45 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.34 -20.49 66.42 Favored 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 122.022 -0.424 . . . . 0.0 110.564 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 152.63 -39.95 0.73 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.466 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 31.7 t80 71.82 147.92 0.08 Allowed 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 122.332 1.063 . . . . 0.0 113.144 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.13 -62.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.7 t 178.48 112.68 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 83.9 m 66.24 103.93 0.04 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . 0.428 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 10.7 m-20 -143.05 -39.2 0.33 Allowed 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 415' ' ' LEU . 7.8 pt -104.1 -24.17 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.51 2.553 0 CA-C-N 119.271 0.941 . . . . 0.0 111.068 -178.776 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.502 2.142 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -72.2 -172.26 0.85 Allowed 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 123.267 2.645 . . . . 0.0 113.112 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.06 128.83 39.18 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-O 121.0 0.429 . . . . 0.0 110.288 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 84.22 -5.38 80.51 Favored Glycine 0 N--CA 1.512 3.718 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.805 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -104.86 138.73 40.66 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 118.22 1.01 . . . . 0.0 109.705 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.4 tp -172.35 105.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 CA-C-O 121.173 0.511 . . . . 0.0 110.902 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -103.67 102.96 12.83 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.02 -19.76 65.96 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.14 -27.75 69.29 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 122.019 -0.426 . . . . 0.0 110.518 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 155.1 -41.58 0.6 Allowed Glycine 0 N--CA 1.511 3.655 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.479 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 34.2 t80 70.88 148.11 0.08 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.233 1.016 . . . . 0.0 113.079 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.78 -63.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.9 t -177.84 101.27 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.4 m 70.85 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.131 0 C-N-CA 123.01 0.524 . . . . 0.0 109.693 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . 0.434 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 8.9 m-20 -147.84 -54.12 0.21 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.19 -0.319 . . . . 0.0 111.148 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 415' ' ' LEU . 6.6 pt -81.44 -29.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 O-C-N 122.105 -0.372 . . . . 0.0 111.941 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.502 2.132 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.431 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.918 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.86 -171.96 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.088 2.525 . . . . 0.0 112.172 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.82 129.27 41.3 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 122.024 -0.423 . . . . 0.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.99 -30.26 8.78 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.918 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -76.42 135.05 39.44 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 117.528 0.664 . . . . 0.0 110.009 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -165.88 112.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-O 121.051 0.453 . . . . 0.0 111.136 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.463 ' CD2' ' HB2' ' A' ' 423' ' ' ASP . 0.4 OUTLIER -111.14 122.81 48.82 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.535 0.683 . . . . 0.0 109.778 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.33 -23.93 67.14 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.877 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -15.69 63.63 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-N 118.357 0.526 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 119.87 -4.97 12.75 Favored Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 17.9 t80 77.68 146.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.206 1.003 . . . . 0.0 112.687 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 420' ' ' ILE . 0.1 OUTLIER -140.92 -57.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.537 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 6.6 t -171.14 -132.61 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.875 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 80.3 m -72.12 107.72 4.94 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.778 -1.202 . . . . 0.0 107.884 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . 0.463 ' HB2' ' CD2' ' A' ' 415' ' ' LEU . 4.3 m-20 -125.41 -30.85 3.08 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.79 -11.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 CA-C-N 118.965 0.802 . . . . 0.0 112.671 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.506 2.333 0 CA-C-N 119.283 0.947 . . . . 0.0 110.81 -179.64 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.947 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 110.505 -0.184 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.79 -177.94 3.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.965 2.443 . . . . 0.0 112.285 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 130.76 48.13 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 121.988 -0.445 . . . . 0.0 110.301 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.71 -28.32 12.85 Favored Glycine 0 N--CA 1.511 3.673 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.947 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.05 137.31 45.24 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 117.811 0.805 . . . . 0.0 110.185 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.8 tp -161.9 111.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-O 121.168 0.509 . . . . 0.0 110.888 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.7 mm? -104.67 116.96 32.94 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -25.95 68.49 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.85 -9.36 57.43 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 122.038 -0.414 . . . . 0.0 111.851 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 117.45 -3.91 17.86 Favored Glycine 0 N--CA 1.512 3.73 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.718 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 24.1 t80 73.56 146.28 0.08 Allowed 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.252 1.025 . . . . 0.0 113.21 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -59.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.151 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 5.5 t -166.98 -129.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.1 t -75.17 131.73 40.65 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 119.842 1.201 . . . . 0.0 108.938 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . 0.814 ' HB2' HD21 ' A' ' 415' ' ' LEU . 17.1 m-20 -145.61 -55.02 0.29 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.553 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.9 pt -84.56 -32.89 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 O-C-N 122.015 -0.428 . . . . 0.0 111.285 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 N--CA 1.505 2.311 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.85 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.951 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.507 2.416 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.09 -174.57 2.13 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.961 2.44 . . . . 0.0 112.146 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.54 129.8 43.75 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 122.015 -0.428 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.89 -29.29 10.12 Favored Glycine 0 N--CA 1.51 3.582 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.951 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.86 137.92 44.05 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 117.601 0.701 . . . . 0.0 110.297 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.65 111.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 CA-C-O 121.221 0.534 . . . . 0.0 111.191 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.879 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.6 mm? -106.03 118.69 37.27 Favored 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -62.56 -25.67 68.18 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.948 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.22 2.41 13.25 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.929 -0.482 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.52 8.18 46.92 Favored Glycine 0 N--CA 1.511 3.674 0 O-C-N 121.122 -0.986 . . . . 0.0 110.816 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.75 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 17.2 t80 71.2 148.05 0.08 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.18 0.99 . . . . 0.0 113.218 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.29 -56.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.704 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.3 t -173.72 -125.14 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.2 m -78.37 124.39 28.05 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.912 -1.118 . . . . 0.0 108.474 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . 0.879 ' HB2' HD21 ' A' ' 415' ' ' LEU . 19.3 m-20 -144.22 -54.67 0.35 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.436 -0.165 . . . . 0.0 111.283 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 413' ' ' TYR . 4.5 pt -85.56 -29.85 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.801 0 O-C-N 121.869 -0.52 . . . . 0.0 111.556 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . 0.406 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 14.8 m-20 . . . . . 0 N--CA 1.504 2.263 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 36.4 Cg_endo -74.87 -168.24 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 123.324 2.683 . . . . 0.0 112.91 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 131.58 51.4 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.3 89.13 Favored Glycine 0 N--CA 1.511 3.67 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -111.87 137.69 49.5 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.344 1.072 . . . . 0.0 109.875 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.5 tp -171.4 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 CA-C-O 121.216 0.532 . . . . 0.0 110.359 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -100.74 112.03 24.37 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.388 0.613 . . . . 0.0 109.386 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.28 -26.29 68.71 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.008 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.38 -26.72 66.86 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 122.244 -0.285 . . . . 0.0 111.203 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.01 -28.93 2.47 Favored Glycine 0 N--CA 1.51 3.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.448 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 18.2 t80 75.01 148.35 0.1 Allowed 'General case' 0 N--CA 1.51 2.545 0 CA-C-O 122.04 0.924 . . . . 0.0 112.706 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 420' ' ' ILE . 0.1 OUTLIER -143.77 -60.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.711 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.4 t 178.9 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 m 70.29 122.46 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.063 0.545 . . . . 0.0 109.961 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -148.68 -52.22 0.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.224 -0.298 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.465 HG23 HD21 ' A' ' 415' ' ' LEU . 5.6 pt -85.02 -28.41 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 O-C-N 121.996 -0.44 . . . . 0.0 111.824 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.503 2.199 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.205 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.972 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.507 2.395 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.03 -176.81 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 123.042 2.495 . . . . 0.0 112.202 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.62 131.2 49.24 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 122.014 -0.429 . . . . 0.0 110.298 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.64 -23.94 30.18 Favored Glycine 0 N--CA 1.51 3.628 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.972 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -75.55 138.03 41.23 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 118.022 0.911 . . . . 0.0 110.368 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.01 111.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-O 121.121 0.486 . . . . 0.0 111.014 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.5 mm? -105.01 118.66 37.09 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.92 -25.4 68.31 Favored 'General case' 0 N--CA 1.518 2.961 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.876 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.28 0.45 16.59 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.992 -0.442 . . . . 0.0 111.958 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.43 5.49 42.68 Favored Glycine 0 N--CA 1.511 3.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.757 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 23.1 t80 70.97 146.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.38 1.086 . . . . 0.0 113.405 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 -59.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.324 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 4.9 t -168.18 -131.07 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.9 m -76.11 120.71 21.78 Favored 'General case' 0 N--CA 1.512 2.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.441 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . 0.857 ' HB2' HD21 ' A' ' 415' ' ' LEU . 20.8 m-20 -139.34 -60.54 0.56 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.459 -0.151 . . . . 0.0 110.934 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 413' ' ' TYR . 5.1 pt -72.37 -29.09 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 122.082 -0.386 . . . . 0.0 110.86 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.502 2.152 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.043 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.786 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.503 2.207 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 33.7 Cg_endo -72.15 -174.76 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.276 2.651 . . . . 0.0 112.978 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.67 125.85 24.11 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.373 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.08 -36.74 3.66 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.786 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.9 135.66 45.13 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.415 -0.462 . . . . 0.0 109.991 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -170.21 102.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 CA-C-O 121.214 0.531 . . . . 0.0 110.665 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -96.19 113.2 24.78 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.13 -26.36 67.63 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 122.134 -0.354 . . . . 0.0 111.223 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.55 2.32 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.421 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 24.0 t80 74.82 147.83 0.09 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 122.213 1.006 . . . . 0.0 112.818 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 420' ' ' ILE . 0.1 OUTLIER -144.01 -60.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.243 179.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.2 t 177.26 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 68.1 m 65.16 107.1 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 120.973 0.416 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -144.19 -39.49 0.29 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.517 HG23 HD21 ' A' ' 415' ' ' LEU . 7.6 pt -102.54 -23.49 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.511 2.596 0 CA-C-N 119.29 0.95 . . . . 0.0 111.005 -178.76 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' ALA . . . . . 0.752 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . . . . . . 0 N--CA 1.504 2.238 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.5 Cg_endo -70.37 -178.0 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.234 2.622 . . . . 0.0 113.169 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.61 125.6 22.94 Favored 'General case' 0 N--CA 1.517 2.889 0 CA-C-O 120.965 0.412 . . . . 0.0 110.375 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.53 -37.48 3.4 Favored Glycine 0 N--CA 1.51 3.617 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.752 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.54 137.34 44.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.978 0.511 . . . . 0.0 110.076 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.8 tp -173.22 107.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.601 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -102.26 111.17 23.35 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.26 -25.85 68.51 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.09 -26.86 66.53 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.09 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.51 -32.87 1.71 Allowed Glycine 0 N--CA 1.51 3.593 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' PHE . . . . . 0.437 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 26.2 t80 72.67 148.84 0.09 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 122.006 0.907 . . . . 0.0 112.617 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -62.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.927 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 17.4 t -179.4 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.2 m 70.73 121.65 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.001 0.52 . . . . 0.0 109.657 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -145.99 -55.89 0.29 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.12 -0.362 . . . . 0.0 111.066 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 415' ' ' LEU . 7.3 pt -81.21 -29.17 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.504 2.23 0 CA-C-O 121.822 0.82 . . . . 0.0 108.834 179.742 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 420' ' ' ILE . 33.4 m . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 121.335 0.588 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -120.44 160.7 22.58 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.333 0.587 . . . . 0.0 111.316 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -109.24 115.17 56.96 Favored Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 35.7 Cg_endo -74.79 -171.8 1.06 Allowed 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 123.192 2.595 . . . . 0.0 112.801 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.64 127.64 33.19 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.2 5.73 Favored Glycine 0 N--CA 1.51 3.627 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.883 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -75.54 133.81 40.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 122.854 0.461 . . . . 0.0 110.024 179.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.865 0 CA-C-O 120.998 0.428 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.72 123.51 50.04 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.696 0.76 . . . . 0.0 109.525 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.19 -23.2 67.23 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.443 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -19.38 65.78 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 118.541 0.609 . . . . 0.0 111.177 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 123.55 -11.05 8.5 Favored Glycine 0 N--CA 1.506 3.346 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 11.2 t80 77.11 147.15 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 118.123 0.962 . . . . 0.0 111.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 407' ' ' CYS . 0.1 OUTLIER -138.85 -63.4 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.457 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 407' ' ' CYS . 27.2 t 177.68 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.713 HG22 ' HG2' ' A' ' 426' ' ' GLU . 7.2 m 69.84 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 122.943 0.497 . . . . 0.0 109.689 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -148.12 -53.48 0.19 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 122.054 -0.404 . . . . 0.0 111.243 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 5.0 pt -88.96 -32.91 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 O-C-N 121.948 -0.47 . . . . 0.0 111.368 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . 0.414 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 16.2 m-20 -112.3 72.69 0.78 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.713 ' HG2' HG22 ' A' ' 422' ' ' THR . 2.0 mt-10 . . . . . 0 N--CA 1.51 2.568 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.359 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 121.049 0.452 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.09 159.03 23.93 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 121.213 0.53 . . . . 0.0 110.913 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.748 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -83.15 120.18 75.45 Favored Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.7 Cg_endo -71.11 -176.46 1.87 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 123.239 2.626 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.19 125.55 22.25 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-O 120.941 0.4 . . . . 0.0 110.384 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.91 -37.97 3.26 Favored Glycine 0 N--CA 1.51 3.624 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.748 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.17 136.86 46.58 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 122.926 0.49 . . . . 0.0 109.819 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 3.0 tp -169.71 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 CA-C-O 121.147 0.499 . . . . 0.0 110.622 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.444 ' HB2' ' HD1' ' A' ' 419' ' ' PHE . 4.5 mm? -101.77 110.61 22.63 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.366 0.603 . . . . 0.0 109.445 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -25.74 68.3 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.804 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.88 -27.41 66.67 Favored 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 122.396 0.278 . . . . 0.0 111.173 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 141.58 -31.43 2.13 Favored Glycine 0 N--CA 1.512 3.722 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.444 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 17.4 t80 75.14 148.83 0.1 Allowed 'General case' 0 N--CA 1.51 2.555 0 CA-C-O 122.116 0.96 . . . . 0.0 112.745 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.86 -59.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.65 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.9 t 178.13 96.12 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 6.2 m 70.21 122.66 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 C-N-CA 123.145 0.578 . . . . 0.0 110.082 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -145.75 -60.68 0.33 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 122.075 -0.391 . . . . 0.0 111.031 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.91 -32.23 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 O-C-N 122.233 -0.292 . . . . 0.0 111.137 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.64 62.12 0.71 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.512 2.666 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 -179.19 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.6 148.27 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 CA-C-O 121.822 0.82 . . . . 0.0 112.261 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.809 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -91.41 124.48 61.02 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.853 -0.529 . . . . 0.0 109.818 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.76 -177.19 2.07 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 123.165 2.576 . . . . 0.0 113.096 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.6 125.75 23.6 Favored 'General case' 0 N--CA 1.516 2.866 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.342 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.66 -36.99 3.54 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.809 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.26 136.29 44.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.403 -0.469 . . . . 0.0 110.013 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.9 tp -171.1 104.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 CA-C-O 121.111 0.481 . . . . 0.0 110.675 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -98.53 112.55 24.55 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -61.26 -28.84 69.46 Favored 'General case' 0 N--CA 1.515 2.811 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.54 -31.66 68.16 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 122.299 -0.251 . . . . 0.0 110.942 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 147.36 -31.45 1.41 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.1 t80 75.03 147.25 0.09 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.277 1.037 . . . . 0.0 113.098 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.18 -63.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.5 t -179.49 105.94 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.661 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 67.16 116.53 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 CA-C-O 121.558 0.694 . . . . 0.0 110.231 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -149.76 -60.91 0.21 Allowed 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.849 -0.532 . . . . 0.0 111.128 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.511 HG23 HD21 ' A' ' 415' ' ' LEU . 5.9 pt -75.9 -36.76 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.832 0 O-C-N 122.191 -0.318 . . . . 0.0 111.765 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.65 65.63 0.77 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.508 2.437 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.761 -178.905 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.41 150.58 0.06 Allowed 'General case' 0 N--CA 1.517 2.88 0 CA-C-O 121.809 0.814 . . . . 0.0 112.308 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -93.95 125.84 51.44 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.902 -0.499 . . . . 0.0 109.864 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -70.83 -177.62 2.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.164 2.576 . . . . 0.0 113.161 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.42 125.78 23.52 Favored 'General case' 0 N--CA 1.516 2.838 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.458 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.45 -37.09 3.5 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.805 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.07 136.04 44.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.353 -0.498 . . . . 0.0 110.012 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.68 105.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.7 0 CA-C-O 121.188 0.518 . . . . 0.0 110.519 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.556 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -99.59 112.08 24.34 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.23 -27.36 67.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 122.247 -0.283 . . . . 0.0 111.118 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.96 -33.41 1.63 Allowed Glycine 0 N--CA 1.511 3.669 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 29.1 t80 73.05 147.64 0.09 Allowed 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 122.15 0.976 . . . . 0.0 113.015 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 -63.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.42 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 426' ' ' GLU . 6.8 m 70.02 118.61 0.04 OUTLIER 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 122.989 0.516 . . . . 0.0 109.888 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . 0.414 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 11.8 m-20 -148.28 -54.79 0.2 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 122.226 -0.296 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.556 HG23 HD21 ' A' ' 415' ' ' LEU . 6.6 pt -81.39 -29.4 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.897 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -106.7 71.28 0.85 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.781 ' HG2' HG22 ' A' ' 422' ' ' THR . 11.8 mt-10 . . . . . 0 N--CA 1.512 2.649 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.379 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.72 174.25 10.82 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 121.439 0.638 . . . . 0.0 111.42 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.766 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -108.52 112.89 60.57 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -71.86 -173.92 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.293 2.662 . . . . 0.0 113.319 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.21 125.3 20.08 Favored 'General case' 0 N--CA 1.516 2.826 0 CA-C-O 120.966 0.413 . . . . 0.0 110.459 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.01 -34.49 4.76 Favored Glycine 0 N--CA 1.509 3.553 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.766 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -74.33 134.07 42.54 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 117.17 0.485 . . . . 0.0 110.225 179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -172.38 102.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 CA-C-O 121.119 0.485 . . . . 0.0 110.632 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.615 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -96.79 112.99 24.51 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.65 -26.94 68.89 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.97 -26.88 67.87 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 122.208 -0.307 . . . . 0.0 111.17 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.07 -33.39 1.72 Allowed Glycine 0 N--CA 1.51 3.613 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.445 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 27.4 t80 73.72 147.62 0.09 Allowed 'General case' 0 N--CA 1.507 2.408 0 CA-C-O 122.193 0.997 . . . . 0.0 113.139 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.77 -61.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.282 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 7.5 t 179.5 110.88 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.415 HG22 ' CD ' ' A' ' 426' ' ' GLU . 86.5 m 64.49 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 CA-C-O 120.999 0.428 . . . . 0.0 109.914 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . 0.432 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 13.2 m-20 -142.25 -37.13 0.4 Allowed 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.615 HG23 HD21 ' A' ' 415' ' ' LEU . 7.2 pt -105.61 -24.36 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.167 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.91 64.81 1.26 Allowed 'General case' 0 N--CA 1.511 2.581 0 CA-C-N 119.222 0.919 . . . . 0.0 111.0 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.415 ' CD ' HG22 ' A' ' 422' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.507 2.393 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.386 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 66.27 150.65 0.05 Allowed 'General case' 0 N--CA 1.516 2.857 0 CA-C-O 121.742 0.782 . . . . 0.0 112.264 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -91.57 122.45 65.77 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 121.871 -0.518 . . . . 0.0 109.764 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.4 Cg_endo -70.95 -176.38 1.79 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.218 2.612 . . . . 0.0 113.163 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.24 125.43 21.76 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.54 -37.53 3.38 Favored Glycine 0 N--CA 1.511 3.645 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.776 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.98 136.75 45.16 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 122.859 0.464 . . . . 0.0 109.997 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.5 tp -170.6 103.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.789 0 CA-C-O 121.231 0.539 . . . . 0.0 111.224 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -101.02 104.31 15.45 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.34 -20.49 66.42 Favored 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.155 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 122.022 -0.424 . . . . 0.0 110.564 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 152.63 -39.95 0.73 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.466 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 31.7 t80 71.82 147.92 0.08 Allowed 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 122.332 1.063 . . . . 0.0 113.144 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.13 -62.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.7 t 178.48 112.68 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.415 HG22 ' CD ' ' A' ' 426' ' ' GLU . 83.9 m 66.24 103.93 0.04 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . 0.428 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 10.7 m-20 -143.05 -39.2 0.33 Allowed 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 415' ' ' LEU . 7.8 pt -104.1 -24.17 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.67 64.36 1.28 Allowed 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 119.271 0.941 . . . . 0.0 111.068 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.415 ' CD ' HG22 ' A' ' 422' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.506 2.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.383 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.32 154.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 121.896 0.855 . . . . 0.0 112.774 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -92.8 122.51 63.79 Favored Pre-proline 0 N--CA 1.502 2.142 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.98 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -72.2 -172.26 0.85 Allowed 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 123.267 2.645 . . . . 0.0 113.112 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.06 128.83 39.18 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-O 121.0 0.429 . . . . 0.0 110.288 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 84.22 -5.38 80.51 Favored Glycine 0 N--CA 1.512 3.718 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.805 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -104.86 138.73 40.66 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 118.22 1.01 . . . . 0.0 109.705 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.4 tp -172.35 105.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.813 0 CA-C-O 121.173 0.511 . . . . 0.0 110.902 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.597 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -103.67 102.96 12.83 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -66.02 -19.76 65.96 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.14 -27.75 69.29 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 122.019 -0.426 . . . . 0.0 110.518 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 155.1 -41.58 0.6 Allowed Glycine 0 N--CA 1.511 3.655 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.479 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 34.2 t80 70.88 148.11 0.08 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.233 1.016 . . . . 0.0 113.079 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.78 -63.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 11.9 t -177.84 101.27 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 426' ' ' GLU . 7.4 m 70.85 118.48 0.04 OUTLIER 'General case' 0 N--CA 1.522 3.131 0 C-N-CA 123.01 0.524 . . . . 0.0 109.693 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . 0.434 ' CB ' ' HG ' ' A' ' 415' ' ' LEU . 8.9 m-20 -147.84 -54.12 0.21 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.19 -0.319 . . . . 0.0 111.148 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.597 HG23 HD21 ' A' ' 415' ' ' LEU . 6.6 pt -81.44 -29.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.892 0 O-C-N 122.105 -0.372 . . . . 0.0 111.941 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.83 71.16 0.83 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.778 ' HG2' HG22 ' A' ' 422' ' ' THR . 10.7 mt-10 . . . . . 0 N--CA 1.512 2.637 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.417 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 6.0 m . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.36 161.29 25.0 Favored 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 121.337 0.589 . . . . 0.0 111.164 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.918 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -105.5 116.36 60.29 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 122.09 -0.381 . . . . 0.0 110.222 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.86 -171.96 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.088 2.525 . . . . 0.0 112.172 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -58.82 129.27 41.3 Favored 'General case' 0 N--CA 1.512 2.664 0 O-C-N 122.024 -0.423 . . . . 0.0 110.409 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.99 -30.26 8.78 Favored Glycine 0 N--CA 1.511 3.682 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.918 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.2 OUTLIER -76.42 135.05 39.44 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 117.528 0.664 . . . . 0.0 110.009 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -165.88 112.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 CA-C-O 121.051 0.453 . . . . 0.0 111.136 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.463 ' CD2' ' HB2' ' A' ' 423' ' ' ASP . 0.4 OUTLIER -111.14 122.81 48.82 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.535 0.683 . . . . 0.0 109.778 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.33 -23.93 67.14 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.877 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -15.69 63.63 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-N 118.357 0.526 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 119.87 -4.97 12.75 Favored Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.68 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 17.9 t80 77.68 146.57 0.09 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.206 1.003 . . . . 0.0 112.687 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 420' ' ' ILE . 0.1 OUTLIER -140.92 -57.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.537 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 407' ' ' CYS . 6.6 t -171.14 -132.61 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.875 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 80.3 m -72.12 107.72 4.94 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 120.778 -1.202 . . . . 0.0 107.884 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . 0.463 ' HB2' ' CD2' ' A' ' 415' ' ' LEU . 4.3 m-20 -125.41 -30.85 3.08 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.79 -11.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.055 0 CA-C-N 118.965 0.802 . . . . 0.0 112.671 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -117.96 75.5 1.01 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.283 0.947 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.51 2.53 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.233 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 65.93 153.63 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 CA-C-O 121.729 0.776 . . . . 0.0 112.482 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.947 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -114.56 133.49 22.5 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 121.916 -0.49 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -75.79 -177.94 3.97 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.965 2.443 . . . . 0.0 112.285 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.66 130.76 48.13 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 121.988 -0.445 . . . . 0.0 110.301 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.71 -28.32 12.85 Favored Glycine 0 N--CA 1.511 3.673 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.947 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.05 137.31 45.24 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 117.811 0.805 . . . . 0.0 110.185 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.8 tp -161.9 111.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.665 0 CA-C-O 121.168 0.509 . . . . 0.0 110.888 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.7 mm? -104.67 116.96 32.94 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -25.95 68.49 Favored 'General case' 0 N--CA 1.517 2.895 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.609 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -70.85 -9.36 57.43 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 122.038 -0.414 . . . . 0.0 111.851 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 117.45 -3.91 17.86 Favored Glycine 0 N--CA 1.512 3.73 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.718 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 24.1 t80 73.56 146.28 0.08 Allowed 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.252 1.025 . . . . 0.0 113.21 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.81 -59.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.151 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 5.5 t -166.98 -129.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.1 t -75.17 131.73 40.65 Favored 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 119.842 1.201 . . . . 0.0 108.938 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . 0.814 ' HB2' HD21 ' A' ' 415' ' ' LEU . 17.1 m-20 -145.61 -55.02 0.29 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.553 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 4.9 pt -84.56 -32.89 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 O-C-N 122.015 -0.428 . . . . 0.0 111.285 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -115.23 71.7 0.77 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 N--CA 1.509 2.496 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.369 -179.356 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.725 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -122.14 151.1 41.3 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.951 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -99.99 120.82 55.94 Favored Pre-proline 0 N--CA 1.507 2.416 0 O-C-N 122.104 -0.372 . . . . 0.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.09 -174.57 2.13 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.961 2.44 . . . . 0.0 112.146 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.54 129.8 43.75 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 122.015 -0.428 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.89 -29.29 10.12 Favored Glycine 0 N--CA 1.51 3.582 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.951 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.86 137.92 44.05 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 117.601 0.701 . . . . 0.0 110.297 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.65 111.06 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 CA-C-O 121.221 0.534 . . . . 0.0 111.191 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.879 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.6 mm? -106.03 118.69 37.27 Favored 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -62.56 -25.67 68.18 Favored 'General case' 0 N--CA 1.517 2.915 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.948 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.22 2.41 13.25 Favored 'General case' 0 N--CA 1.515 2.791 0 O-C-N 121.929 -0.482 . . . . 0.0 111.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.52 8.18 46.92 Favored Glycine 0 N--CA 1.511 3.674 0 O-C-N 121.122 -0.986 . . . . 0.0 110.816 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.75 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 17.2 t80 71.2 148.05 0.08 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.18 0.99 . . . . 0.0 113.218 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.29 -56.97 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.704 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 407' ' ' CYS . 9.3 t -173.72 -125.14 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.764 HG22 ' HG2' ' A' ' 426' ' ' GLU . 18.2 m -78.37 124.39 28.05 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.912 -1.118 . . . . 0.0 108.474 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . 0.879 ' HB2' HD21 ' A' ' 415' ' ' LEU . 19.3 m-20 -144.22 -54.67 0.35 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 122.436 -0.165 . . . . 0.0 111.283 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 413' ' ' TYR . 4.5 pt -85.56 -29.85 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.801 0 O-C-N 121.869 -0.52 . . . . 0.0 111.556 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . 0.406 ' HB2' ' HE1' ' A' ' 413' ' ' TYR . 14.8 m-20 -114.6 73.49 0.83 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.764 ' HG2' HG22 ' A' ' 422' ' ' THR . 1.8 mt-10 . . . . . 0 N--CA 1.51 2.563 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.263 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.04 0.447 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -120.25 160.98 21.88 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.304 0.573 . . . . 0.0 110.955 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -84.24 116.6 65.7 Favored Pre-proline 0 N--CA 1.506 2.337 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 413' ' ' TYR . 36.4 Cg_endo -74.87 -168.24 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 123.324 2.683 . . . . 0.0 112.91 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 131.58 51.4 Favored 'General case' 0 N--CA 1.512 2.64 0 CA-C-O 120.97 0.414 . . . . 0.0 110.24 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.3 89.13 Favored Glycine 0 N--CA 1.511 3.67 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -111.87 137.69 49.5 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 118.344 1.072 . . . . 0.0 109.875 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.5 tp -171.4 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 CA-C-O 121.216 0.532 . . . . 0.0 110.359 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 424' ' ' ILE . 4.6 mm? -100.74 112.03 24.37 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.388 0.613 . . . . 0.0 109.386 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.28 -26.29 68.71 Favored 'General case' 0 N--CA 1.515 2.798 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.008 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.38 -26.72 66.86 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 122.244 -0.285 . . . . 0.0 111.203 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.01 -28.93 2.47 Favored Glycine 0 N--CA 1.51 3.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.448 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 18.2 t80 75.01 148.35 0.1 Allowed 'General case' 0 N--CA 1.51 2.545 0 CA-C-O 122.04 0.924 . . . . 0.0 112.706 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 420' ' ' ILE . 0.1 OUTLIER -143.77 -60.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.711 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 10.4 t 178.9 97.37 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.817 HG22 ' HG2' ' A' ' 426' ' ' GLU . 7.0 m 70.29 122.46 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 123.063 0.545 . . . . 0.0 109.961 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -148.68 -52.22 0.17 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.224 -0.298 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.465 HG23 HD21 ' A' ' 415' ' ' LEU . 5.6 pt -85.02 -28.41 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.808 0 O-C-N 121.996 -0.44 . . . . 0.0 111.824 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.56 73.85 0.84 Allowed 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.817 ' HG2' HG22 ' A' ' 422' ' ' THR . 3.8 mt-10 . . . . . 0 N--CA 1.511 2.605 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 1.1 m . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 66.15 151.18 0.06 Allowed 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.712 0.767 . . . . 0.0 112.404 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.972 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -114.39 132.64 22.71 Favored Pre-proline 0 N--CA 1.507 2.395 0 O-C-N 121.925 -0.484 . . . . 0.0 110.449 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -76.03 -176.81 3.23 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 123.042 2.495 . . . . 0.0 112.202 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.62 131.2 49.24 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 122.014 -0.429 . . . . 0.0 110.298 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.64 -23.94 30.18 Favored Glycine 0 N--CA 1.51 3.628 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.972 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -75.55 138.03 41.23 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 118.022 0.911 . . . . 0.0 110.368 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 1.6 tp -160.01 111.18 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-O 121.121 0.486 . . . . 0.0 111.014 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 423' ' ' ASP . 3.5 mm? -105.01 118.66 37.09 Favored 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.92 -25.4 68.31 Favored 'General case' 0 N--CA 1.518 2.961 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.876 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.28 0.45 16.59 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 121.992 -0.442 . . . . 0.0 111.958 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.43 5.49 42.68 Favored Glycine 0 N--CA 1.511 3.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.757 ' CE1' ' HB2' ' A' ' 409' ' ' ALA . 23.1 t80 70.97 146.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.38 1.086 . . . . 0.0 113.405 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.42 -59.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.324 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 407' ' ' CYS . 4.9 t -168.18 -131.07 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.9 m -76.11 120.71 21.78 Favored 'General case' 0 N--CA 1.512 2.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.441 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . 0.857 ' HB2' HD21 ' A' ' 415' ' ' LEU . 20.8 m-20 -139.34 -60.54 0.56 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.459 -0.151 . . . . 0.0 110.934 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 413' ' ' TYR . 5.1 pt -72.37 -29.09 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 O-C-N 122.082 -0.386 . . . . 0.0 110.86 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.16 58.59 0.65 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.514 2.729 0 C-N-CA 123.192 0.597 . . . . 0.0 110.222 -179.408 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 121.02 0.438 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.75 161.1 28.11 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.317 0.58 . . . . 0.0 110.894 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.786 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -87.4 118.19 69.56 Favored Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 33.7 Cg_endo -72.15 -174.76 1.47 Allowed 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.276 2.651 . . . . 0.0 112.978 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.67 125.85 24.11 Favored 'General case' 0 N--CA 1.514 2.76 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.373 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 95.08 -36.74 3.66 Favored Glycine 0 N--CA 1.511 3.664 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.786 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -72.9 135.66 45.13 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 122.415 -0.462 . . . . 0.0 109.991 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.1 tp -170.21 102.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 CA-C-O 121.214 0.531 . . . . 0.0 110.665 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -96.19 113.2 24.78 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.057 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.13 -26.36 67.63 Favored 'General case' 0 N--CA 1.513 2.704 0 O-C-N 122.134 -0.354 . . . . 0.0 111.223 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.55 2.32 Favored Glycine 0 N--CA 1.51 3.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.421 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 24.0 t80 74.82 147.83 0.09 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 122.213 1.006 . . . . 0.0 112.818 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 420' ' ' ILE . 0.1 OUTLIER -144.01 -60.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.243 179.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 9.2 t 177.26 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.441 HG22 ' CD ' ' A' ' 426' ' ' GLU . 68.1 m 65.16 107.1 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 120.973 0.416 . . . . 0.0 110.028 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -144.19 -39.49 0.29 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.517 HG23 HD21 ' A' ' 415' ' ' LEU . 7.6 pt -102.54 -23.49 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.211 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.66 64.37 1.11 Allowed 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 119.29 0.95 . . . . 0.0 111.005 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.441 ' CD ' HG22 ' A' ' 422' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.508 2.43 0 O-C-N 121.943 -0.473 . . . . 0.0 110.369 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.98 142.12 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 123.691 0.797 . . . . 0.0 111.81 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' ALA . . . . . 0.752 ' HB1' ' HB3' ' A' ' 413' ' ' TYR . . . -89.65 124.89 62.91 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.798 -0.564 . . . . 0.0 109.693 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 413' ' ' TYR . 32.5 Cg_endo -70.37 -178.0 2.35 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.234 2.622 . . . . 0.0 113.169 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.61 125.6 22.94 Favored 'General case' 0 N--CA 1.517 2.889 0 CA-C-O 120.965 0.412 . . . . 0.0 110.375 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' GLY . . . . . . . . . . . . . . . 94.53 -37.48 3.4 Favored Glycine 0 N--CA 1.51 3.617 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.752 ' HB3' ' HB1' ' A' ' 409' ' ' ALA . 0.3 OUTLIER -73.54 137.34 44.3 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.978 0.511 . . . . 0.0 110.076 178.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 2.8 tp -173.22 107.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.601 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 424' ' ' ILE . 4.5 mm? -102.26 111.17 23.35 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.26 -25.85 68.51 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.038 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.09 -26.86 66.53 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.09 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 144.51 -32.87 1.71 Allowed Glycine 0 N--CA 1.51 3.593 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.437 ' HD1' ' HB2' ' A' ' 415' ' ' LEU . 26.2 t80 72.67 148.84 0.09 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 122.006 0.907 . . . . 0.0 112.617 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -62.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.927 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . . . . . . . . . 17.4 t -179.4 97.36 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 426' ' ' GLU . 7.2 m 70.73 121.65 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.001 0.52 . . . . 0.0 109.657 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -145.99 -55.89 0.29 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 122.12 -0.362 . . . . 0.0 111.066 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 415' ' ' LEU . 7.3 pt -81.21 -29.17 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.805 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.03 69.13 0.93 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.822 0.82 . . . . 0.0 108.834 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' A' ' 422' ' ' THR . 15.8 mt-10 . . . . . 0 N--CA 1.511 2.616 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 -179.138 . . . . . . . . 1 1 . 1 stop_ save_